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Epigenetics mainly refers to the biological phenomena that can alter gene 
expression and cellular differentiation without changing the underlying DNA sequences 
in the genome. The two main components of epigenetic regulation are DNA methylation 
and histone modifications (1,2).  Both have been shown to be highly related with gene 
expression, and histone modifications, compared to DNA methylation, are more complex 
given that the tails of histone proteins can be modified by a variety of histone modifying 
enzymes. Different histone modifications are related with or participate in distinct 
regulatory processes and mark distinct regulatory elements, including transcription 
initiation, elongation, enhancers, insulators, imprinting and three-dimensional chromatin 
structures (3-11). Thus, a thorough understanding of the specific patterns of histone 
modification profiles and their associations with various genomic features is very 
important in functional genome biology research. Some general discoveries have been 
drawn from a number of studies on the dynamics of histone modifications in different cell 
types (3,4,7,12-18). But detailed analyses of the complex and diverse associations of 
histone modifications with genome regulatory systems, along with the underlying 
mechanisms, are still currently lacking. 
Due to recent advances in next-generation high-throughput sequencing 
technology, experimental biologists have combined the chromatin immunoprecipitation 
technique with high-throughput sequencing (ChIP-seq) to obtain the genome-wide maps 
of various functional factors, including suites of histone modifications and transcription 
factors, in a number of cell types of different species (3,18,19). These large-scale datasets 
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provide rich sources of information for important regulatory functional systems or 
pathways of gene expression and cellular differentiation. In order to globally characterize 
the epigenomic modification landscape and its interaction with other transcription factors, 
effective and efficient computational algorithms and pipelines are needed.  The 
development of such tools and approaches will play a critical role for the progress of 
research in epigenetics and gene regulation (19). 
The algorithms and analyses that result from my own Ph.D. dissertation research 
provide both novel methods for basic data processing and advanced tools of information 
mining and pattern recognition for important biological questions. The specific advances 
of my research in the field of computational epigenomics are summarized as follows: 
Research advance 1: A Gibbs sampling algorithm was developed to accurately 
map short ambiguous sequence tags back to the reference genome. Employing the 
information of neighboring tag-mapping profile information, the algorithm is the first 
which models the ambiguous read mapping problem in a unified Bayesian inference 
framework. It achieves better performances compared with existing methods, with 
respect to the higher fractions of correctly mapped ambiguous tags and higher accuracies 
of recovered real genomic sites measured by the recall, precision and F scores.  The 
applications of this algorithm are shown to be able to discover more important biological 
signals in repetitive genomic regions, including transposable elements, simple repeats, 
peri-centromeric regions and segmental duplications. 
Research advance 2: A broad peak calling algorithm was developed to identify 
enriched contiguous regions of diffuse ChIP-seq signals. Combining a Gibbs sampling 
procedure for parameter estimations of non-homogeneous Poisson processes and the 
xvii 
 
maximal scoring segment algorithm, the method is capable of identifying broad peaks of 
various sizes, especially for certain histone modifications which can have peaks over 1 
Mb. Compared with existing algorithms, this method requires many fewer parameters 
and is more data-adaptive. Applications of the method on simulated datasets prove that it 
has better recall and F scores, and it has better coverage for larger broad peaks. 
Application of this method to real ChIP-seq datasets from human cells shows that this 
algorithm is also useful for finding biologically meaningful patterns, such as large-scale 
chromatin states with particular regulatory meanings. 
Research advance 3: A hypothesis-driven computational pipeline was designed to 
search for MIR retrotransposon derived insulators (MIR-insulators) and a list of such 
predicted insulators is found. This work presents one of the first reports of CTCF-
independent insulators in the human genome. Several of the predicted MIR-insulators are 
experimentally validated by enhancer-blocking assays (EBA) in both human kidney cell 
lines and zebrafish embryos. Chromatin signatures, including histone modification 
profiles and RNA polymerase II and III bindings, are characterized for those putative 
MIR-insulators. Functional analysis of genes proximal to those MIR-insulators uncover 
that the T-cell receptor (TCR) pathway is enriched, and an interesting example of three 
adjacent TCR genes with pairs of MIR-insulators encompassing them is found. 
Comparative analysis of chromatin environments in different cell types classifies the 
MIR-insulators into cell type invariant and cell type specific groups. 
Research advance 4: An unbiased (hypothesis-free) algorithm was developed to 
search for chromatin boundary elements in the human genome with possibly novel 
features and mechanisms. A list of boundary elements is predicted and a subset of them is 
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CTCF-independent. The classical boundary element BEAD1 (also the only one which is 
experimentally validated in human CD4
+
 T cells) is successfully found by this algorithm. 
Specific combinatorial chromatin signatures are identified for those boundary elements 
and a set of interesting protein factors are predicted to be associated with boundary 
activity, including EVI1, USF and YY1. A subset of this list contains non-coding RNAs 
that are actively transcribed and bound by RNA polymerase III (Pol III). This is the first 
report of non-coding RNA, specifically tRNA, derived boundary elements in the human 
genome. 
Research advance 5: An unsupervised algorithm was developed to predict novel 
combinatorial chromatin signatures without being restricted to the annotated genomic 
features or training datasets. As a high-dimensional pattern recognition method, it can do 
exploratory data analysis of genomic ChIP-seq datasets of various histone modifications 
and an inherent statistical criterion is derived for the final pattern identifications. The 
resulting combinatorial signatures are found to be related with distinct genomic features, 
such as transcriptional start sites (TSS), transcription termination sites (TTS), enhancers, 
conserved non-coding elements (CNE) and L1 retrotransposons. Bivalent signatures are 
also found and associated with cell type specific gene expression silencing. An additional 
advantage of this algorithm is that it is able to find both small and large signatures with 
very complex combinatorial profiles, e.g. spatially shifted enrichments of different 
histone modifications. Several large signatures are found to be highly related with gene 








Epigenetics and gene expression regulation 
Variations of cellular phenotypes can exist even if the cells have identical 
genomic DNA sequences. These phenomena, along with their underlying mechanisms, 
are collectively called epigenetics (1,2). The two major topics of epigenetics research are 
DNA methylation and histone modifications. DNA methylation refers to the addition of 
methyl group to the 5
 
position of cytosine pyrimidine ring, and clear negative 
associations between DNA methylation states in promoter regions and gene expression 
levels have been observed in a number of studies (20). Compared to DNA methylation, 
histone modifications bear much more varieties, and their relationships with gene 
expression and cell differentiation are complex.  Within each nucleosome, i.e. the basic 
units of chromatin structure, two copies of four histone proteins (H2A, H2B, H3 and H4) 
are wrapped around by DNA sequences, and the amino terminal tails of those histone 
proteins can be modified by different enzymes. The main types of histone modifications 
include acetylations, methylations, phosphorylations and ubiquitylations (1,2). Beyond 
the different types of histone modifications, the complexity comes mainly from the 
distinct locations on the tails of different histone proteins where the modifications occur. 
For example, the di-methylation of lysine 9 of H3 (H3K9me2) has very different effects 
compared with the di-methylation of lysine 4 of H3 (H3K4me2).  
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The basic models for the associations of histone modifications and gene 
expression can be classified into the following hypotheses (1,21). First, different histone 
modifications can change the local chromatin structure and thus affect the accessibility of 
the DNA sequences to transcription factors and/or RNA polymerase. Second, specific 
histone modifications and their associated chromatin enzymes can possibly be the 
recognition targets and recruit specific transcription factors that are necessary for 
transcription activation or repression. Third, specific histone modifications can be 
consequences, instead of causes, of different gene expression states.  
Regardless of the detailed mechanistic hypotheses, a general picture of the 
associations between different histone modifications and gene expression 
activation/repression has emerged based on recent genome-wide analyses 
(3,7,8,11,16,18,22-24). Globally, histone modifications associated with active 
transcription and open chromatin are called active modifications and the ones associated 
with repressed transcription and closed chromatin are called repressive modifications. In 
promoter proximal regions, a set of histone modifications that are characteristic of open 
chromatin structures are strongly associated with active transcription initiation, including 
H3K4me3, H3K27ac and H3K9me1. In gene bodies, several broadly distributed histone 
modifications are associated transcription elongation, including H3K36me3, H3K79me2 
and H3K79me3. In distal intergenic regions, some discrete locations that are marked by 
specific active modifications, including H3K4me1 and H3K27ac, are associated with 
active expression of genes and have been suggested as regulatory elements in trans. And 
a few specific repressive modifications are widely enriched within the repressive 
chromatin states, e.g. heterochromatin domains. 
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Besides the basic associations with specific gene expression patterns, the 
dynamics of histone modifications are largely related with cellular differentiation and 
reprogramming (7,12,14-16,21,25). Comparative analyses of the genome-wide 
landscapes of different histone modifications in various cell types have suggested that 
specific cell types are characterized by distinct histone modification profiles. One of the 
interesting observations is that some gene promoters modified by bivalent patterns (i.e. 
co-occurrence of active an repressive modifications) are paused for transcription in stem 
cells but turn to active transcriptions in differentiated cell types where the promoters 
become marked by active modifications alone (12). Most recently, the chromatin 
modifying enzymes are further shown to be modulators of cell type reprogramming 
which will help for mechanistic explanations of the relationship between histone 
modification landscape dynamics and cellular differentiation (26). 
The biological importance of histone modifications is not restricted to their 
associations with gene expression. They are related with diverse biological pathways and 
the histone modification signatures contain abundant information to predict specific 
regulatory elements and distinct functional activities, including enhancers, insulators, 
replication timing, alternative splicing and three-dimensional chromatin looping (3,5,6,8-
11,17,23-25,27-34). The most thoroughly studied case is enhancers. Distinct histone 
modification signatures are found to be informative to identify the cell type specific 
locations of enhancers (9,28,29). Thus, analyzing the genomic landscapes of histone 





ChIP-seq data analysis for epigenomics 
The development of next-generation high-throughput sequencing technologies has 
enabled genome-wide analyses of histone modifications. By combining the chromatin 
immunoprecipitation technique with next-generation sequencing (ChIP-seq), researchers 
can effectively identify genomic locations of different histone modifications (using 
distinct antibodies). Compared with traditional experimental approaches, ChIP-seq has 
the following advantages: 1) it is more high-throughput and easier to scale up, 2) it has 
better signal to noise ratios, and 3) it has higher resolution for the locations of 
modifications (19). Due to these advantages, ChIP-seq has been employed by a number 
of genome-wide studies to investigate the distribution patterns of a suite of histone 
modifications in different species and cell types. As the experimental technique is now 
mature, more challenges come from the subsequent computational data analysis steps. In 
the last few years, many computational algorithms have been developed for effective and 
efficient data mining and analysis of large-scale ChIP-seq datasets. This new field is 
often referred to as computational epigenomics. 
Generally speaking, computational epigenomic data analysis is composed of two 
different fields: 1) basic data processing, and 2) biological question driven data mining 
(Figure 1.1). The basic data processing deals directly with the short sequence tags (or 
reads) produced by ChIP-seq and generates genomic mapping profiles of tags that are 
noise reduced and can be analyzed for specific biological questions. Next, depending on 
the specific questions of interest, biological question driven data mining develops 
corresponding advanced algorithms which transform the genomic profiles of ChIP-seq 











There are two major steps in basic data processing, i.e. sequence read mapping 
and peak calling (Figure 1.1). Read mapping is the first and most important step of ChIP-
seq data analysis since all subsequent analyses rely on accurate mappings of ChIP-seq 
reads. The main challenge is to make time-efficient methods for short sequence 
alignments that are applicable for large amounts of reads. There have been several 
successful algorithms available for read mapping (35-37), and one remaining problem is 
about ambiguous reads (also called as multi-mapping reads) which can be aligned to 
multiple genomic locations with almost identical sequence similarities. One solution for 
the ambiguous read mapping problem will be discussed in details in this dissertation. 
After accurate read mapping, the next critical data processing step is peak calling, namely 
identifying discrete genomic regions that have significantly higher tag-counts compared 
to the background noise levels (38-42). It can also be considered as noise reduction 
processing. The resulted discrete locations with significant tag-counts represent the real 
sites of the histone modifications or transcription factors, and characterize the basic 
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landscapes of ChIP-seq profiles. The current methods mostly restricted their focuses on 
sharp and abrupt peaks, i.e. densely located small genomic bins with high tag-counts 
(38,39,42). Although this kind of peaks fit well with the observed features of some 
histone modifications and most transcription factors, certain histone modifications are 
widely distributed along large genomic regions without characteristic size ranges and 
accordingly their ChIP-seq datasets are diffuse (19). The corresponding peaks are called 
broad peaks and a novel algorithm for broad peak calling will be discussed later in this 
dissertation. 
After the basic data processing, specific data mining algorithms are needed to 
solve different interesting biological questions (Figure 1.1). Depending on the specific 
biological question, descriptive features of the problem of interest are usually formulated 
into quantitative signatures or patterns. Based on the diverse characteristics of the 
signatures or patterns, appropriate pattern recognition algorithms need to be carefully 
selected and designed. Several interesting biological questions will be described in the 
following sections (Figure 1.1) and the corresponding analytical methods are detailed in 
subsequent chapters. 
Enhancers and Insulators 
Gene expression regulation is a complex process. Besides cis regulation through 
transcription factors, other types of regulations in trans also play critical roles, including 
enhancers and insulators. Enhancers can be located distal from their target gene 
promoters and are able to activate transcriptions in a cell-type specific manner. 
Chromatin looping is proposed to form via specific to connect the enhancer with its target 
promoter (28). Insulators are located between enhancers and their target promoters 
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(43,44). In the appropriate cell types, functional insulators can block the interactions of 
enhancers and promoters such that transcription will not be activated from the promoter. 
In this sense, insulators are classified as negative regulators. Another interesting feature 
of insulators is that they are not able to block enhancer-promoter interactions if they are 
located outside of the regions enclosed by enhancer-promoter pairs. Based on these 
features, different hypothetical models are proposed for insulator mechanisms, such as 
disturbances of local chromatin structures that block enhancer-promoter interactions, 
formations of three dimensional loops that partition enhancers and promoters into distinct 
domains and competing with promoters for the preferential interactions of enhancers 
(43,44).  
As an important class of regulatory elements, insulators have been investigated 
for many years and there are several experimentally validated insulators in different 
species.  In drosophila, a gypsy transposable element located between an enhancer and a 
promoter can be bound by proteins Su(Hw) and mdg4, and block the transcription 
activation caused by the enhancer (45,46). Another insulator, called 5‟HS4 element, is 
found in the β-globin locus in the chicken genome (47-49). This insulator is the most 
investigated one in vertebrate species and its associated protein, CTCF, has been shown 
to be widely associated with insulator functions (50,51). 
Among all the experimentally validated insulators, there is no unified mechanistic 
model to explain their functions. But for a subset of insulators, RNA polymerase III (Pol 
III) is shown to be a critical part of the system. In yeast, some tRNA genes (which are 
transcribed by Pol III) function as insulators and furthermore (52,53), many more 
locations that are bound by TFIIIC (a subunit of Pol III) can also function as insulators 
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(52,54). Similar results of tRNA-derived insulators are recently found in mouse (55). 
Most interestingly, a SINE B2 transposable element in the mouse genome, which evolved 
from tRNA, can be transcribed by Pol III and function as an insulator in a developmental 
stage dependent manner (56). Collecting these observations from different species 
together, Pol III machinery is highly probable to be related with insulator functions, at 
least for a subset of them. Actually, an evolutionary hypothesis has been proposed to 
suggest that some insulators originally evolved from Pol III promoters (57). 
Chromatin boundary elements 
Another related class of regulatory elements is called chromatin boundary 
elements or chromatin barriers. Chromatin boundary elements can block the spread of 
repressive chromatin domains, which are enriched with repressive histone modifications, 
and thus protect the active transcription within open chromatin domains (43). The ability 
of boundary elements to partition the chromatin into repressive domains 
(heterochromatin) and active domains (euchromatin) makes them to be related with 
insulators, because they can potentially block enhancer-promoter interactions by 
demarcating them into different domains (44,45,48). Actually boundary elements are 
sometimes classified as a subgroup of insulators due to this overlap of phenotypic 
outcomes, although the conceptual distinction is also clear. 
Since chromatin boundary elements can change and restrict the landscape of 
large-scale chromatin domains, they can be viewed as higher-order regulators that 
function in long distance and influence groups of gene expression. The importance of 
boundary elements is further underscored by the fact that the linear configurations of 
active and repressive domains along chromosomes are also related with three 
9 
 
dimensional chromatin structures (58). Some boundary elements have been shown to 
interact with each other to form hubs of three dimensional chromatin interactions 
(50,52,59-61).  
Despite their importance, there is no clear unified model of the boundary element 
mechanisms and the number of experimentally validated barriers is limited. A 
straightforward algorithm based on one aspect of the observed features derived from a 
few known boundary element examples will just detect putative elements with the same 
features and unable to find barriers with different, or even novel, features. A carefully 
designed unbiased algorithm is needed to explore candidate boundary element locations 
with various features that are indicative of the underlying mechanisms.  
Combinatorial chromatin signatures 
At this time, the relationships between individual histone modifications and gene 
expression patterns have been studied a great deal and a general picture for the role of 
individual histone modifications has begun to emerge. Nevertheless, the much more 
complex relationships between different combinations of histone modifications with 
various biological activities and regulatory elements, such as transcriptional initiation, 
transcriptional termination, cell-type specific expression, enhancers and imprinting, have 
been under investigated. Although systematic analysis of this question is difficult, a 
hypothesis called the “histone code”, which proposes the specific relations between 
combinatorial histone modification signatures and different biological activities, has been 
raised based on some biochemical observations (21). Several canonical histone code has 
been found in the last few years (9,28,29,32,62). For instance, active promoters are 
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associated with combinations of H3K4me3, H3K9me1 and several histone acetylations. 
Cell type specific enhancers are characterized by H3K4me1and H3K27ac. 
As large-scale ChIP-seq datasets of various histone modifications in different cell 
types are accumulating, computational algorithms to search for distinct novel 
combinatorial histone modifications patterns and relating them with diverse genomic 
features will be valuable for the understanding of the regulatory functions of histone 
modifications. Furthermore, given the detailed locations of specific combinatorial 
chromatin signatures and their associations, comparative analysis among different cell 
types will reflect the dynamics of epigenetic regulation.  
Overview of the dissertation 
This dissertation focuses exclusively on the development and application of 
computational algorithm for ChIP-seq data analysis that are related with epigenomics. It 
contains both basic data processing methods and advanced data mining algorithms aimed 
at specific biological questions.  
CHAPTER 2 presents a novel algorithm to accurately map ambiguous short 
ChIP-seq tags to reference genome sequences. Systematic performance comparisons with 
previous methods are reported for a set of simulated ChIP-seq data libraries. The utilities 
of this algorithm for the discoveries of biological signals within repetitive genomic 
regions are discussed. 
CHAPTER 3 presents a method to identify broad peaks of diffuse ChIP-seq 
datasets. Besides the use of the maximal scoring segment algorithm, a detailed discussion 
on parameter estimations via Gibbs sampling on non-homogeneous Poisson processes is 
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reported. Evaluations of the algorithmic performance on both real ChIP-seq datasets and 
simulated datasets are shown. 
CHAPTER 4 presents a hypothesis-driven computational pipeline that predicts a 
specific subset of insulators: MIR-insulators. Both genomic and epigenomic features are 
integrated into this pipeline and a list of putative MIR-insulators are predicted. Several 
selected putative MIR-insulators are further experimentally validated. Functional 
annotations of genes proximal to those putative MIR-insulators, investigations on the 
local chromatin signatures, and the analysis of cell type specificity, are carried out for the 
predicted insulators. 
CHAPTER 5 presents an unbiased algorithm to predict the locations of chromatin 
boundary elements in the human genome. The successful prediction of BEAD1 element 
is emphasized, and also the potential capabilities to discover elements with novel features 
are explored. The associations of the predicted boundary elements with CTCF binding 
and a set of chromatin features are analyzed. Some novel transcription factor binding 
motifs are shown to be enriched within those boundaries. A subset of boundaries 
containing non-coding RNAs genes are further analyzed for the binding of Pol III and the 
transcription states. 
CHAPTER 6 presents a new unsupervised algorithm to search for recurrent 
combinatorial histone modification signatures. Applications of this algorithm resulted in 
a set of chromatin patterns and their relationships with diverse genomic features are 
systematically analyzed. The computational advantages of this algorithm are discussed in 





A GIBBS SAMPLING STRATEGY APPLIED TO THE MAPPING OF 





Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-
seq) is widely used in biological research.  ChIP-seq experiments yield many ambiguous 
tags that can be mapped with equal probability to multiple genomic sites. Such 
ambiguous tags are typically eliminated from consideration resulting in a potential loss of 
important biological information. We have developed a Gibbs sampling based algorithm 
for the genomic mapping of ambiguous sequence tags. Our algorithm relies on the local 
genomic tag context to guide the mapping of ambiguous tags. The Gibbs sampling 
procedure we use simultaneously maps ambiguous tags and updates the probabilities used 
to infer correct tag map positions. We show that our algorithm is able to correctly map 
more ambiguous tags than existing mapping methods. Our approach is also able to 
uncover mapped genomic sites from highly repetitive sequences that can not be detected 
based on unique tags alone, including transposable elements, segmental duplications and 
peri-centromeric regions. This mapping approach should prove to be useful for increasing 




Genome-wide chromatin immunoprecipitation followed by high throughput 
sequencing (ChIP-seq) experiments are increasingly used in biological and medical 
research (3,19). ChIP-seq experiments produce a large amount of short sequence tags 
which need to be faithfully mapped back to the genome and processed to reveal 
biologically relevant signal. A number of algorithms have been recently developed to 
process ChIP-seq data (63). These include algorithms for genomic mapping of sequence 
tags (35,37), smoothing of ChIP-seq tag distribution signals (64) and detection of 
statistically significant tag peaks (65). One remaining challenge for the processing of 
ChIP-seq data is the mapping of ambiguous tags. Ambiguous tags are those that can be 
mapped to equally to multiple genomic sites, each of which has significant sequence 
similarity with the tag, and thus it is difficult to distinguish the real site from all the 
possible sites. Usually, researchers simply disregard ambiguous tags and only make use 
of uniquely mapped tags. This often results in a substantial loss of information and may 
bias conclusions based on the analysis of unique tags alone. This is particularly true for 
mammalian genomes, such as the human genome, which have numerous interspersed 
repeat sequences. Repeat sequences that are highly similar may produce a large amount 
of ambiguous tags, which if not mapped will be disregarded in subsequent analyses. 
Research has shown that interspersed repeat sequences provide a wide variety of 
functional elements to eukaryotic genomes (66). Therefore, disregarding ambiguous tags 
will cause an underestimate of the biological significance and functional roles of 
interspersed repeated DNA. 
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 Two different approaches have been developed for the mapping of ambiguous 
sequence tags. The mapping software MAQ randomly selects a possible site and assigns 
it to the ambiguous tag (35). Each possible site has the same probability of being 
selected. In other words, there is no way to know if this approach yields a correct 
mapping of ambiguous tags. The second approach takes advantage of the local context of 
mapped tags to more accurately assign genomic locations for ambiguous tags. This 
approach rests on the assumption that real ambiguous tag sites are expected to have more 
sequence tags in the local vicinity, whereas the incorrect sites for the same ambiguous 
tags are expected to have fewer numbers of co-located tags (36,67). To apply this method 
for any ambiguous tag, the number of overlapping mapped tags at each of the possible 
ambiguous tag mapped positions are counted and used to assign fractional weights to 
each possible position. The ambiguous tag is then fractionally mapped to each possible 
position with the fractions weighted by the local mapped tag context. In other words, 
possible sites with more tags already mapped are deemed to deserve higher confidence 
and are accordingly assigned greater fractions of ambiguous tags. The fractional mapping 
method makes important contribution to the ambiguous tag mapping problem. But as the 
use of ChIP-seq in scientific research is increasing, it will be important to further refine 
the accuracy of mapping ambiguous tags. First, the fraction method is heuristic as the 
fractions assigned to the possible map sites are directly proportional to the number of tags 
mapped to each site. While this approach is consistent with biological intuition, it lacks 
statistical support. A more sensitive probabilistic method could be used to better 
represent and measure the confidence level of each possible site. Second, the fraction 
method deterministically fractionates the ambiguous tags without guarantee that the result 
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is optimal. In other words, it doesn‟t search the possible space of assignments of 
ambiguous tags and lacks information on the accuracy of the final results. Third, the 
fraction method is not realistic enough since it splits tags by assigning fractions of 
ambiguous tags to each possible site. In reality, each sequence tag is only derived from a 
single genomic site. Thus, fractioning sequence tags inevitably results in wasting signal 
on incorrect sites and weakening the signal level on real sites. 
To address the outstanding issues with ambiguous tag mapping, we have 
developed a probabilistic Gibbs sampling based algorithm to map more ambiguous tags 
with greater accuracy. Our approach assigns ambiguous tags to single genomic sites, 
without fractionating tags, and iteratively samples within the space of the possible 
mappings of ambiguous tags. The Gibbs sampling strategy (68,69) guides the algorithm 
to achieve accurate unique mappings of ambiguous tags. The algorithm also provides 
statistical support for ambiguous tag mapping via the use of likelihood ratios that 
measure the confidence levels of possible genomic map sites. We evaluated the 
performance of our algorithm compared to existing approaches using sequence tag data 
from the highly repetitive human genome. We demonstrate that our probabilistic 
approach to mapping ambiguous tags yields superior results as measured by 1) the 
fraction of correctly mapped ambiguous tags, 2) the precision and recall of correctly 




Overview of the algorithm 
Our algorithm maps ambiguous tags to individual genomic sites by taking 
advantage of the local genomic context provided by co-located tags. For each possible 
map site of an ambiguous tag, the number of co-located tags are counted and used to 
calculate a normalized likelihood ratio that represents its probability of being the real 
map site. Map sites are randomly selected based on the underlying probability 
distributions from the likelihood ratios. Likelihood ratio scores then updated based on the 
new mapping, and this procedure iterates until convergence when there is little or no 
change in the map positions between iterations. 
A Gibbs sampling strategy is used to iteratively map ambiguous tags to possible 
genomic sites while updating the probability that each tag is mapped to its most likely 
site. Gibbs sampling was chosen because it allows for a simultaneous updating of the 
map positions and the parameters for these positions. Through the updating iterations, the 
algorithm searches in the space of all possible mapping configurations, where each 
mapping configuration can be considered as a bipartite graph with edges connecting tags 
and sites (Figure 2.1). Intuitively, once an ambiguous tag is correctly mapped to the real 
site, it will guide the algorithm to map those tags derived from the same site to it with 
higher probability. 
Problem formulation 
For each ambiguous tag, there are multiple possible genomic sites to which it 
could be assigned. It is not possible to assign a specific site to an ambiguous tag with 100 
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percent confidence, and so we need to calculate the confidence for each probable site by 
some measurement and then select a reasonable site for each ambiguous tag based on 
those confidences. By “reasonable”, we mean a selection of sites that will minimize the 
number of incorrect mappings of ambiguous tags. Suppose there are T genomic sites 
associated with ambiguous tags and the set of ambiguous tags is }......,{ 21 NaaaA , where 
i
a  represents ambiguous tag i . We use }......,{ 21 iiniii sssS to denote the set of probable 













Figure 2.1: Scheme of our Gibbs sampling algorithm. Possible tag map sites along 
with their likelihood ratios are shown prior to stochastic mapping. Gray boxes reprsent 
incorrect sites, and the black box represents the correct site. An arrow between a tag and 
a site means the tag could possibly be mapped to that site. One iterative cycle of joint 
stochastic mapping and parameter updating is shown. The black arrows point to selected 




There are two aspects of this problem. One is the measurement of confidence for 
each probable site, and the other one is the algorithm used to select reasonable sites for 
ambiguous tags. An applicable measurement of confidences of probable sites needs to be 
monotonic with the number of tags that are mapped to each specific site and should 
reflect both the information of the distribution of tag numbers of real sites and the 
information of the distribution of tag numbers of background. We use likelihood ratio as 
the confidence measurement based on both intuitive clues and theoretical analysis. 
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Intuitively, likelihood ratio is monotonic with tag counts and is also computationally 
tractable. Furthermore, it takes both the background distribution of tag counts and the 
estimated target distribution under consideration. Higher likelihood ratios correspond to 
higher confidences and increase non-linearly with tag counts. Likelihood ratios will 
increase sharply for large tag counts and be relatively low for sites with few tags. This 
property will help to avoid the problem of wasting fractions of mapped tags on sites that 
contain few tags; a problem that could be particularly vexing if many such low 








sP is the estimated target distribution of tag counts in real sites and nP is the 
background distribution of tag counts. jk is the tag count at site j . The details of these two 
distributions will be discussed in the next section. Given the calculated likelihood ratios, 
it is possible for us to reasonably map ambiguous tags.  
Furthermore, from a theoretical point of view, normalized likelihood ratio is the 
measurement we will automatically derive from the calculation of the conditional 
probability of assigning ambiguous tags to a specific site given the assignments of all the 
other tags. We use D to denote the original data, which essentially represent the 
associations of tags with possible sites, and M to denote the whole assignment of tags to 
sites. ][ iM represents the assignments of tags to sites, except the assignment of tag i . 
),|~( ][ DMsaP iiji represents the conditional probability of assigning tag i to the j th 
probable site of i , given the original data and the assignment of all tags except tag i . We 
use U to represent the whole set of sites.  
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Below we show that this conditional probability is equal to the normalized 







































So the normalized likelihood ratio represents the conditional probability for the 
j th probable site given the assignment of other tags. Equivalently, this conditional 
probability serves as our predictive update formula for the Gibbs sampling procedure 
described below. 
In order to calculate likelihood ratios for genomic sites, we need to first map those 
ambiguous tags to get the number of tags mapped to each specific site. In other words, 
mapping of ambiguous tags and calculating the likelihood ratios for each site are circular. 
This circularity led us to adopt Gibbs sampling strategy, which is a stochastic version of 
EM algorithms, to select reasonable sites for ambiguous tags. To do this, we first 
initialize the likelihood ratios for genomic sites using the total number of tags that can be 
probably mapped. Then we map each ambiguous tag to a specific site based on the initial 
likelihood ratios. To be more specific, we stochastically map each ambiguous tag to a 
genomic site with the probability equal to the normalized likelihood ratio of the site. 
Then we update the likelihood ratios given the current mapping of ambiguous tags. We 
continue the update on the mapping and the calculation of likelihood ratios until there is 
no significant change. Through the iterative updates (stochastic mapping and parameter 
updating), the overall likelihood ratios are expected to be optimized, and so we achieve 
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an accurate mapping of ambiguous tags. Since the complete normalized likelihood ratio 








( , where i is the index of 
genomic sites with tags mapped, we can rewrite this formula based on tag counts and 








s , where )(n represents the number of sites 
with tags mapped. Here, represents the set of tag counts for all sites. For instance, if 
consists of large numbers, it means that most sites are mapped with large number of 
tags and the mapping is a reasonable one. Otherwise, most sites are mapped with a small 
number of tags and the set of tags are scattered into diverse sites. Taking the logarithm of 












When Z is sufficiently large, it approaches the relative entropy between sP and nP on the 
subset of . So essentially, the Gibbs sampling procedure described above searches a 
certain subset  to maximize the relative entropy. When consists of only large 
numbers, the relative entropy is larger. This analysis further demonstrates that our 
algorithmic design is reasonable. The equation above shows that by using normalized 
likelihood ratios, our objective function is equivalent to the relative entropy. 
In theory, Gibbs sampling will have good performance given a sufficient number 
of iterations.  Thus, there may be concerns about the time necessary for the algorithm to 
converge. However, since unique tags count for the majority of the whole set of tags, and 
these help to guide the mapping of ambiguous tags, this has the effect of shortening the 





Next we describe each step of the algorithm in detail along with the definitions of 
necessary concepts. The scheme of the method is shown in Figure 2.1. 
Phase 1. Initialization 
Step 0. The program Bowtie (37) is used to map all sequence tags to the genome 
and only genomic loci with significant sequence similarities are used for the following 
steps. Sequence tags are classified into unique tags and ambiguous tags by the Bowtie 
mapping algorithm. 
Step 1. To calculate the likelihood ratios, we need to model the distributions of 
tag counts for real modified sites (
sP ) and for background ( nP ). For real modified sites, 
we use the Normal distribution to approximate the real distribution of tag number 
)2,(~ NPs . 
To identify genomic sites that are most likely to actually be modified (i.e. real 
modified sites), we use sites with large numbers of mapped unique tags.  We then use the 
numbers of unique tags associated with those sites to calculate the average tag count and 
standard deviation for each site genome-wide.  Note that the average tag count calculated 
here is corrected by a factor which takes into consideration that the real average tag count 
will be greater once ambiguous tags are included. For background, we use the Poisson 
distribution to approximate the background distribution of tag counts: )(~ PoissonPn . 
The Poisson distribution is an appropriate model for counting processes that 
produce rare random events and thus can be applied here to describe the background tag 
count distribution. We count the total number of tags (both unique and ambiguous tags) 
and calculate the average tag number for each site. The average tag number serves as the 
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parameter ( ) of Poisson distribution. After getting all the parameters, we calculate the 








s , and get a table of likelihood 
ratios which will be used in subsequent steps. 
Step 2.  In order to obtain the initial settings of likelihood ratios for all the 
probable genomic loci, we use the number of tags of each site (both unique and 
ambiguous tags) to calculate the likelihood ratios. Since the ambiguous tags have not 
been assigned to a specific genomic site, here we assign each ambiguous tag to all the 
probable sites to initialize the likelihood ratios. The calculation of likelihood ratios for 
various tag numbers has already been done in Step 1 and the algorithm only needs to 
search the table of likelihood ratios. A special notion here is that we introduce the 
information content factor ( 10 f ) of ambiguous tags compared to unique tags. Since 
the nature of uncertainty of ambiguous tags, the information content of ambiguous tags is 
smaller than unique tags. Thus, the effective number of ambiguous tags (
ek ) is corrected 
by f  and the number of tags used to calculate likelihood ratio is: 
fkkkkk aueu ,  where uk is the number of unique tags and ak is the number of 
ambiguous tags. f can be set by the user based on their confidence of ambiguous tags 
and provide flexibility of the method. The suggested value of f  is the inverse of the 
mean number of associated sites of ambiguous tags. If the mean number of associated 
sites of ambiguous tags is larger, then f  should be made smaller to weight unique tags 
more heavily for the mapping. 
Phase 2. Iterative weighted mapping 
24 
 
Step 3. Given the likelihood ratio ( jLR ) of probable site j  ( inj ...2,1 ) for 
ambiguous tag 
ia , the algorithm stochastically selects a probable site and assigns it as the 
site of the corresponding ambiguous tag. The probability ( ijP ) of probable site j  to be 
selected for 







P , where 
ink ...2,1 . Thus, probable sites with higher likelihood ratios will have a greater chance 
of being assigned. 
Step 4. Based on the current assignments of sites for ambiguous tags obtained 
from Step 3, the likelihood ratios of all the probable sites are updated. The new likelihood 
ratio of each probable site is obtained accordingly to the current number of tags assigned 
to the site. 
Step 5. Iterate through Step 3 and Step 4 until no significant changes occur, i.e. 
until convergence. For a given threshold, if the number of reassignments of ambiguous 
tags is smaller than the threshold, then the iterations will stop and output the final 
mapping of tags. 
Results 
Sequence tag data sets 
In order to test the performance of our algorithm, we randomly selected ~50,000 
sites of the human genome as a benchmark. Each site is 147bp in length (i.e. mono-
nucleosomal) and the set of sites contains transposable elements and simple repeats in the 
same fractions as the human genome. Then we generate short sequence tags from these 
sites under a range of set of parameters. These parameters include sequence tag length 
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( L ), signal-to-noise ratio ( SNR ) and sequencing error level ( SE ). In theory, shorter 
sequence tags are expected to have more ambiguous tags. To test the performance of our 
algorithm on different sequence tag lengths, we generate libraries with 20bp tags and 
libraries with 35bp tags. SNR  corresponds to the specificity of the ChIP experiments. 
Noise here means the fraction of sequence tags derived from sites which are not the real 
modified sites. In experiments with high specificity, the majority of sequence tags are 
derived from the real modified sites, while in experiments with high level of noise, there 
are increased number of sequence tags derived from other sites. And we define the SNR  
as the ratio of the probability that a sequence tag is derived from the real modified sites 
over the probability that a sequence tag is derived from other sites. To test our 
algorithm‟s performance under different SNRs, we generate libraries with SNR  set as 99 
(corresponds to 99% tags derived from real modified sites) and libraries with SNR  set as 
9 (corresponds to 90% tags derived from real modified sites). The sequencing error level 
corresponds to the probability of errors in high-throughput sequencing. We generate 
libraries with sequencing error levels as )5/(2 L and )5/(4 L . The reason to set SE  this 
way is as follows. We assume that the sequencing errors on different sites are 
independent from each other. This is not completely true in reality but is acceptable as a 
first-order approximation. Then the total number of errors for each sequence tag with 
length L  would follow binomial distribution. So under )5/(2 LSE , the fraction of 
sequence tags without errors is about 60% and under )5/(4 LSE , the fraction is about 
50%. It means that the quality of the simulated sequencing is not very good. Under such 
conditions, some sequence tags might be mis-mapped or become ambiguous tags. The 
purpose of this setting is to make sure that our algorithm test results are conservative. 
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Since each of these three parameters only has two optional values, there are 8 
combinations of different values of those parameters and so we generate one sequence 
tag library for each combination of the parameter values. The parameters for each library 
are listed in Table A.1. 
We also used a second larger benchmark set consisting of 173,877 sites of the 
human genome. These sites were obtained from a ChIP-seq study of histone 
modifications based on ABI SOLiD sequencing platform (unpublished data) that only 
used unique sequence tags, and each site has significant number of tags. This dataset was 
used because it mimics conditions one would expect for real sites: a larger number of 
total sites and a realistic distribution of sites along the human genome. In order to test our 
algorithm, we generated sequence tags for these sites the same way as described above 
under one set of parameters (Table A.1). 
After preparing sequence tags, we ran the program Bowtie (37) to map the 
sequence tags to the human genome. The fractions of ambiguous tags in the 9 libraries 
range from 9.7% to 37.6%. The fraction of sites undetected using unique tags alone are 
influenced by the tag threshold used. Higher threshold cause more undetected sites. For 
the lowest threshold (4 tags) used in our analyses, the fractions of undetected sites range 
from 16.4% to 28.4%. These values underscore the importance of accurately mapping 
ambiguous tags to recover undetected sites. 
Fraction of correctly mapped ambiguous tags 
The first and most direct measurement of the algorithm performance is the 
fraction of correctly mapped ambiguous tags. Since the fraction method does not assign 
the ambiguous tags to a specific site, this measurement is not applicable. So we compared 
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our algorithm against the MAQ software method, which randomly selects a site for each 
ambiguous tag. The comparison on the 8 sequence tag libraries shows that our algorithm 
correctly maps 49% to 71% of ambiguous tags, while the MAQ method correctly maps 
8% to 23% of ambiguous tags (Figure 2.2). Over all eight sequence tag libraries 
evaluated, our algorithm maps 38% to 51% more tags than MAQ. In the best case, our 
algorithm maps the majority of ambiguous tags (71%) and only a small fraction of 






Figure 2.2: Fractions of correctly mapped ambiguous tags for each library. Library 
descriptions are given in Table A.1. Gray bars show results based on MAQ, and black 




Comparison of rescued sites 
The other measurement of the algorithm‟s performance is the numbers and 
fractions of correctly „rescued‟ genomic sites, which can not be observed by unique tags 
alone. An important issue regarding the rescued sites is the tag number threshold, above 
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which a site is called rescued with a certain number of tags (Figure 2.3.A). Different 
thresholds will result in different sets of true positives, false positives and false negatives. 
Since there are various methods to decide the threshold and different users usually set 
different thresholds, we tested our algorithm‟s performance on a set of three different 
thresholds (4 tags, 6 tags and 8 tags). Together with the previously described the 9 
sequence tag libraries we use, this results in a set of 27 conditions for analysis. 
The first thing we did was to compare the numbers of genomic sites identified using 
unique tags alone to the numbers of genomic sites identified by including ambiguous tags 
with our method (Table A.2).  Over the 27 conditions, the inclusion of ambiguous tags 
yields an average increase of 11.46% in the fraction of genomic sites accurately 
identified. The use of ambiguous tags resulted in the identification of 2,602-51,508 sites 
missed with unique tags alone. 
Next we compared our method for including ambiguous tags to the MAQ and 
fraction methods. To do this, after excluding sites that can be found by unique tags alone, 
we divide the set of sites rescued by ambiguous tags into two subsets by comparing the 
set with the benchmark. The correctly rescued sites are true positives (TP ) and other sites 
are false positives ( FP ). The sites in the benchmark which remain undiscovered are false 
negatives ( FN ) (Figure 2.3.B). In order to test the performances, we employ recall 
)/( FNTPTPRE  and precision  )/( FPTPTPPE  as measurements.  
For the four libraries with 35bp tags and the four libraries with 20bp tags, our 
algorithm shows the highest recall over all conditions (6 tag thresholds shown in Figure 
2.3.C, 4 and 8 tag thresholds shown in Figure A.1 and numbers of sites shown in Table 
A.3). Our algorithm also has the highest precision for these libraries over 14 of the 24 
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conditions evaluated (Figure 2.3.C, Figure A.1). For the 10 cases where our algorithm did 
not show the highest precision, the difference from the fractional method was marginal 
(Table A.3). In general, when recall increases precision may be expected to decrease. The 
simultaneous increase in both recall and precision in 14 cases evaluated here supports the 
improved performance of our algorithm. To more quantitatively evaluate the 
improvement in the performance of our algorithm for both recall and precision together, 
we used the harmonic mean (F) of the recall and precision values for each condition (i.e. 
each library and threshold combination). The F-values are higher for our algorithm over 
all conditions, indicating an improvement in performance when recall and precision 
considered together (Table A.4). Similar results can be seen when the larger tag library is 
evaluated with our algorithm over the three thresholds. Recall improves substantially in 
all cases, and precision decreases marginally for thresholds 6 and 8 (Figure 2.3.D and 
Table A.5). The F-values showing the combined recall and precision performance are 
higher for our method over all three thresholds (Table A.4). 
In Figure 2.4, we provide two examples of our mapping results with the 
comparison against the benchmark and the result of fraction method. It can be seen that 
our algorithm rescues more sites than fraction method, and that the average number of 
tags at rescued sites is higher than seen for the fraction method. This can be attributed to 
the fact that the fraction method assigns a fraction of ambiguous tags on each site and 
wastes information on other sites. The greater number of tags per rescued site can help to 
ensure that these sites are robust to different user thresholds that are employed to 
distinguish signal from noise. 
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It should be noted that the two examples shown here represent segmental 
duplications (Figure 2.4.A) and satellite regions (Figure 2.4.B) respectively. It is expected 
that such highly repetitive regions will produce many ambiguous tags and thus would be 
difficult to uncover with ChIP-seq.  However, our method achieves good performance in 
such repetitive regions. Furthermore, the second example is located very near to the 
centromere of chromosome 7. Centromeric regions are important in various cellular 
processes, such as cell division, and correct mapping of ambiguous tags to centromeric 







Figure 2.3: Comparison of algorithm performances. A. Illustration of data used to test 
algorithm performances. B. Variant tag thresholds could cause differences in the 
performance test. The lines (red and green) are two tag thresholds. C. Barplots of recall 
and precision for the three methods (MAQ-dark blue, fraction method-light blue, Gibbs 
method-green) on 8 libraries under 3 different tag thresholds. D. Barplots of recall and 
precision for the three methods (MAQ-dark blue, fraction method-light blue, Gibbs 








Figure 2.4: Examples of ambiguous tag mapping results. Tracks are shown through 
UCSC Genome Browser. The track of real sites shows the sites in the benchmark 
libraries. The track of Fraction method shows the mapping result by fraction method and 
the track of Gibbs method shows the mapping result by our Gibbs method. The heights of 
data represent the number of tags mapped to those sites. The tracks of repetitive genomic 








Transposable elements, simple repeats, micro-satellites, segmental duplications 
and pericentromeric regions are genomic regions rich in repeat sequences. These regions 
could produce large numbers of ambiguous tags and will be difficult to uncover due to 
the technical problem of mapping ambiguous tags. The ability to correctly map 
ambiguous tags may facilitate novel discoveries regarding the biological significance of 
such repeat regions, many of which have been ignored in past chromatin 
immunoprecipitation studies.  For instance, we show that our method is able to detect 
previously uncharacterized segmental duplications and satellite regions in Figure 2.4.  In 
addition, our method uncovered a previously undetected modified histone site in the 
proximal promoter region of the CWF19-like 1 cell cycle control protein.   
To further investigate whether our algorithm really helps us to find more sites in genomic 
repeats, we used the UCSC genome browser (70,71) to count the numbers and fractions 
of rescued sites in those regions and compared them against using unique tags alone 
(Figure 2.5). This analysis demonstrates that our algorithm is able to rescue substantial 
numbers of sites in genomic repeat regions, especially for segmental duplications and 
pericentromeric regions. Unique tags can only uncover around half of the sites in 
segmental duplications and pericentromeric regions, while our algorithm could uncover 
the majority of those sites (Figure 2.5.B). It is evident that our method has the potential to 







Figure 2.5: Recovery of sites in repetitive genomic regions. A. The numbers of 
correctly discovered sites in various genomic features by unique tags alone (white) and 
our Gibbs method (black) compared with the corresponding numbers in the benchmark 
library.  B. The fractions of correctly discovered sites in various genomic features by 
unique tag alone (white) and our Gibbs method (black). [TE: transposable elements; s_r: 








Based on the results described above, we have shown that our algorithm 
significantly improves the accuracy of mapping ambiguous tags. The essential 
information used by the algorithm is the association between co-located sequence tags, 
which was originally utilized by Faulkner and co-workers (36) in the fraction method. 
Our contribution to this class of approach is to employ iterative probabilistic methods to 
achieve better performance. The use of likelihood ratios not only reflects the information 
on sequence tag associations but also the background distribution information. 
Furthermore, likelihood ratios are not linear to tag counts, but increase sharply for large 
tag counts and thus efficiently avoid wasting signal on sites with small tag counts. The 
Gibbs sampling procedure enables us to sample in the space of mapping and achieve a 
reasonable assignment of sites to sequence tags. For most experiments, unique tags are 
the majority of tags and they can guide the sampling efficiently. Thus, Gibbs sampling 
doesn‟t require too much time to reach the final result. We have also shown that correct 
mapping of ambiguous tags can facilitate our understanding of biology by recovering 
repeated genomic sites which are prone to produce ambiguous tags. 
Although the length of sequence tags is increasing, there will still be a certain 
amount of ambiguous tags. As shown in Figure 2.4, genomic sites, such as segmental 
duplications and microsatellites will always produce ambiguous tags by their nature: with 
multiple copies in the genome. So the task of mapping ambiguous tags will not disappear 
due to the experimental technique advancements in short term, and our algorithm 
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Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP--
seq) has been widely used to characterize the genomic distributions of a variety of 
functional features, especially histone modifications. While some histone modifications 
show abrupt enrichment peaks at narrow and specific genomic locations, others have 
diffuse distributions along chromosomes and their large contiguous enrichment 
landscapes are better modeled as broad peaks. Here we present BroadPeak, a broad peak 
calling algorithm for diffuse ChIP-seq datasets. BroadPeak is able to find peaks of very 
different sizes, and its utility is expected to be helpful to the analysis of chromatin states 





Histone modification landscapes are highly related with cell differentiations and 
the analyses of genomic distribution profiles of different histone modifications can help 
to understand the complex regulatory mechanism of the cell (1,2). ChIP-seq technology 
has been used to produce genome-wide maps of a suite of histone modifications in a 
number of cell types (3,7,18,25). To retrieve information from those ChIP-seq datasets, 
one of the critical data processing steps is peak calling, i.e. identifying the contiguous 
genomic regions that are significantly enriched with ChIP-seq tags compared with the 
genomic tag distribution as background (19). Some histone modifications, as well as 
transcription factors, are usually located to specific regions (e.g. promoters) and thus their 
ChIP-seq peaks are narrow and sharp. Computational methods have been developed to 
identify such peaks and their applications are very successful (38,39,42). But some 
histone modification‟s distribution profiles spread out along large contiguous genomic 
regions, e.g. chromatin domains, and accordingly their enriched peaks do not have a 
characteristic size range. For such diffuse datasets, the large regions with enriched ChIP-
seq tags are modeled as broad peaks. Compared to the sharp peaks, which is featured by 
high tag counts of closely adjacent sites, the most important descriptive feature of broad 
peaks is that the spatial densities of sites with high tag counts (high-tag sites) within 
broad peaks are significantly higher than the genomic background. Gaps (i.e. low-tag 
sites) are allowed within broad peaks, and the broad peak sizes can grow to include more 
high-tag sites as far as the spatial densities are significantly high. There have been several 
algorithms designed to solve the broad peak calling problem (40,41). Compared with 
those methods, BroadPeak require fewer parameters and the number of gaps are 
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adaptively determined from the data. Applications of BroadPeak on both real and 
simulated datasets support its good performance for broad peak calling. 
Methods 
Algorithm overview 
The basic idea of BroadPeak is to assign appropriate positive scores to high-tag 
sites and negative scores to low-tag sites (gaps), and model the broad peaks as segments 
with maximal cumulative scores (maximal scoring segments) along chromosomes. 
Considering the cumulative score curve as a random walk along the chromosome, 
maximal scoring segments represent contiguous regions with significantly higher spatial 
densities of high-tag sites which, by our definition, are broad peaks. The input file for 
BroadPeak is the sorted tag-count profiles along chromosomes in bedGraph format. The 
output file is the list of broad peak locations in BED format (Figure 3.1.A).  
Problem formulation 
In the input file, the genome under consideration has been divided into small non-
overlapping genomic bins with equal sizes (e.g. 200bp) and each bin is assigned with a 
tag-count. The bins are first classified into high-tag and low-tag bins based on a tag-count 
threshold derived from the standard tag-count Poisson distribution (which is 
parameterized by the genomic average bin tag-count λ). The regional spatial distributions 
of high-tag bins along chromosomes are expected to be non-homogeneous if broad peaks 
exist. Each high-tag bin is then assigned with a positive score s1, and each low-tag bin is 
assigned with a negative score s2. The cumulative score from bin i to bin j is 
j
ik
kij sc . 
Maximal scoring segments are segments with maximal cumulative scores, i.e. the 
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cumulative scores will decrease if the segments extend to longer segments or shrink to 
shorter segments. Thus, identifications of maximal scoring segments are equivalent to 
setting the boundaries of broad peaks with regional highest spatial densities of high-tag 
bins. 
Scoring scheme and parameter estimations 
The scores (s1 and s2) need to be carefully designed in order to obtain reasonable 
peaks. Based on the theorems proved by Karlin and Altschul (72),  the optimal scoring 
scheme is log likelihood ratios: s1=ln(p/q) and s2=ln((1-p)/(1-q)), where p is the 
estimated spatial density of high-tag bins in real broad peaks and q is the genomic 
background spatial density. Thus p and q are the only parameters needed for BroadPeak. 
One important feature of this scoring scheme is that, as the segment lengths are large, the 
spatial densities within the resulted maximal scoring segments will approximate the real 
target density p (72). This feature theoretically supports the validity of the final identified 
broad peaks since their compositions of high-tag bins will resemble real peaks and it also 
suggests that the gaps will be adaptively allowed based on the data, namely the target and 







Figure 3.1: Scheme and evaluation of BroadPeak. (A) The algorithmic scheme and of 
BroadPeak. (B)  Examples of broad peaks of H3K79me2 and H3K36me3. (C) Examples 
of broad peaks of H3K27me3. (D) Preferential distributions of broad peaks of 
H3K79me2 and H3K36me3. (E) Enrichments of CTCF bindings around the edges of 






In order to accurately estimate the target density p, BroadPeak provides two 
options: supervised and unsupervised estimations (Figure 3.1.A). For supervised 
estimation, user need to provide a list of regions that are enriched with broad peaks based 
on a priori knowledge (e.g. highly transcribed genes can be used for H3K36me3 
parameter estimation). For unsupervised estimation, BroadPeak first uses a sliding 
window approach to obtain an initial set of regions showing spatial density changes and 
model the occurrence of high-tag bins in those regions as non-homogeneous Poisson 
processes with change-points. Conjugate gamma prior distributions are built and a Gibbs 
sampling algorithm is applied to estimate p and q. BroadPeak first uses a sliding window 
approach to scan the genome to sample a list of genomic regions that contain change-
points of spatial densities, i.e. the spatial densities change, at one unknown location 
within the region, from background densities to significantly high densities that are only 
observed in broad peaks.  These regions can be used to simultaneously estimate the target 
density p and background density q. Due to the resolution problem of sliding window 
approaches and the noisy fluctuations of ChIP-seq data, we also need to accurately 
predict the position of the change-point, in order to accurately estimate p and q. It leads 
us to adopt the Gibbs sampling method to iteratively estimate the location of change-
points, p and q. 
We used a 10kb sliding window (each step is bin-size) to scan the genome and 
calculated the high-tag bin densities for each sliding window. If the high-tag bin density 
is higher than twice of the genomic background density, the corresponding window is 
assigned as a putative region containing broad peaks or part of broad peaks.  If we 
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observe a large number of consecutive sliding windows with background densities 
followed by a large number of consecutive sliding windows with putative broad peak 
densities, then the whole region will be used later as a sample for parameter estimation.  
Assume we get N such change-point containing regions after the sliding window 
scan as described above and each region contain L genomic bins, we will divide the L 
bins (for each sample region) into n super-bins and each super-bin is consisted of m 
consecutive bins. Finally, we obtain N data series with length n and they are denoted 
as: ),...,( 21 iniii dddD , where ijd corresponds to the number of high-tag bins in the jth 
super-bin. Due to the way they are sampled, for each data series iD , there exists a super-
bin k such that )(~ 1Poissondij for kj  and )(~ 2Poissondij for kj . So k is the 
unknown change-point and 1 is the rate for background spatial density of high-tag bins 
and 2 is the rate for target spatial density of high-tag bins ( 21 ).  
The whole data series is thus modeled as a non-homogeneous Poisson process 
with two distinct rates. Gibbs sampling has been previously used for parameter 
estimations of non-homogeneous Poisson processes and here we applied this strategy. 
We assume 1 and 2 follow the conjugate prior distributions: 
111 1
11 ~ e and 
222 1
22 ~ e . The prior distributions for the hyperparameters 1 and 2 are: 
111 1
11 ~ e and 
222 1
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ˆ because the change-point is not likely to occur in the first and last a few 
super-bins. Because the prior distributions for 1 and 2 are gamma, and we consider 
1
ˆ and 2
ˆ  are good estimates of the means of the gamma distributions, then 1 is 
initialized as varˆˆ 11 and 2 is initialized as nvar
ˆˆ
22 , where var is the 
variance of the first few super-bins and 
nvar is the variance of the last few super-bins. 
1 is estimated as 111
ˆˆˆ , and 2 is estimated as 222
ˆˆˆ . 1 and 2 are set as 0.5 
and 1 is estimated as 2
ˆˆ
11 , and 2 is estimated as 2
ˆˆ
22 . 
After initializations, we use Gibbs sampling on those conditional probabilities to 
iteratively estimate k, 1 and 2 . Finally, the target spatial density of high-tag bins is 
mp /1 and mq /2 . The estimated densities will then be used to calculate the log 
likelihood ratios as the scores for maximal scoring segment identifications. 
Broad peak identifications 
After estimating parameters and setting scores, BroadPeak applies the linear-time 
Ruzzo-Tompa algorithm (73) to search for all maximal scoring segments (Figure 3.1.A). 
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For each maximal scoring segment, the observed spatial density of high-tag bins is 
compared with the background using z-test and only the ones with significantly higher 
densities (P<0.05) are added to the final broad peak list. Finally a BED format file of 
broad peak locations is generated as the output. 
Results 
Evaluations on real ChIP-seq datasets 
In order to evaluate the performance of BroadPeak, we applied it on the genomic 
ChIP-seq datasets of several diffuse histone modifications in human CD4
+
 T cells (3). 
Investigations of the resulted broad peak examples shows that they are consistent with the 
diffuse ChIP-seq tag count distributions (Figure 3.1.B and 3.1.C).  As a global check of 
the performance, we found that the peaks of H3K79me2 and H3K36me3 concentrate 
around transcriptional start sites (TSS) and transcriptional termination sites (TTS) 
respectively (Figure 3.1.D). Also, we found that the edges of the resulted broad peaks of 
H3K27me3 are more enriched with CTCF binding (Figure 3.1.E). Since CTCF is thought 
to be related with chromatin barriers, its enrichments around the H3K27me3 broad peak 
edges support the performance of BroadPeak to identify repressive chromatin domains. 
Similar results are also observed for broad peaks of H3K9me3 (Figure B.1). We also 
compared the results based on supervised and unsupervised parameter estimations for 
H3K36me3 and they are very similar with each other (Figure B.2). 
Performance comparisons on simulated datasets 
We also generated simulated tag libraries for a list of pre-set broad peaks and 
applied BroadPeak, along with two existing broad peak calling methods: SICER and 
46 
 
RSEG. We first simulated 3 libraries for tests by selecting 5,000 non-overlapping human 
genes with different sizes as the real broad peaks. The human genome is divided into 
200bp bins.  For non-broad-peak regions, the background spatial density of high-tag bins 
is set as 1x10
-4
. For real broad peak regions, the density is set as 20, 50 and 100 fold of 
the background density respectively for different libraries. The tag count distribution of 
high-tag bins is a Gaussian distribution with mean of 8 and standard deviation of 2. The 
spatial density of low-tag bins (noise) is the same throughout the whole genome and is set 
as 0.5, namely about half of the genome have noise. The tag count distribution of low-tag 
bins is a Poisson distribution with the average rate as 0.7, which is similar to the 
H3K36me3 library. Similar to the comparison procedure of RSEG, we run BroadPeak, 
SICER and RSEG on the three simulated libraries and compared the identified broad 
peaks with the real peaks. A real broad peak is considered as correctly identified if a 
certain fraction of it is covered by predicted peaks. Similarly, the predicted broad peak is 
considered as true if a certain fraction of it is covered by real peaks. The three thresholds 
of fractions are 20%, 50% and 80%. Based on these basic counts, recall and precision are 
used to measure the performance and the F score is used as the final measurement of the 
overall performance of the algorithms.  
 Among all the tested simulated datasets, BroadPeak achieves substantial 
improvements on recall (Table B.1 and Figure B.3), while maintaining good precision 
(slightly lower than SICER). The F scores of BroadPeak are the best for all the datasets 
tested. BroadPeak is especially better for larger peaks (Figure B.3). Globally, the size 
distribution of the resulted broad peaks is much wider for BroadPeak, compared with 
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PREDICTION AND VALIDATION OF MIR RETROTRANSPOSON 





Insulators are regulatory sequence elements that help to organize eukaryotic 
chromatin via enhancer-blocking and chromatin barrier activity.  While there are several 
examples of transposable element (TE)-derived insulators, there are no known human 
insulators provided by TEs.  Mammalian-wide interspersed repeats (MIRs) are a 
conserved family of human TEs that have substantial regulatory capacity and share 
sequence characteristics with tRNA-related insulators.  We sought to evaluate whether 
MIRs can serve as insulators in the human genome.  To do this, we applied a 
bioinformatic screen using genome sequence and functional genomic data from CD4
+
 T 
cells to identify a set of 1,178 predicted MIR-insulators genome-wide.  These predicted 
MIR-insulators were computationally validated to serve as chromatin barriers and 
regulators of gene expression in CD4
+
 T cells.  The activity of predicted MIR-insulators 
was experimentally validated using enhancer-blocking assays.  MIR-insulators are 
enriched around genes of the T cell receptor pathway and protect these genes from 
repressive chromatin to facilitate their cell-type specific expression and function.  
Overall, 58% of the MIR-insulators predicted here show evidence of T cell specific 
chromatin barrier and gene regulatory activity.  MIR-insulators show a distinct local 
chromatin environment with marked peaks for RNA Pol III and a number of histone 
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modifications, suggesting that MIR-insulators recruit transcriptional complexes and 
chromatin modifying enzymes in situ to help establish chromatin and regulatory domains 
in the human genome.  The provisioning of insulators by MIRs across the human genome 
suggests a specific mechanism by which TE sequences can be used to establish gene 
regulatory networks. 
Introduction 
Insulators are regulatory sequence elements that help to organize eukaryotic 
chromatin into functionally distinct domains (44,74).  Insulators can encode two different 
functions: enhancer-blocking activity and chromatin barrier activity.  Enhancer-blocking 
insulators prevent the interaction of enhancer and promoter elements located in distinct 
domains, and chromatin barrier insulators, also known as boundary elements (43,75), 
protect active chromatin domains by blocking the spread of repressive chromatin.  These 
two functional roles are not mutually exclusive; compound insulators may encode both 
enhancer-blocking and chromatin barrier activities (48). 
Transposable element sequences are known to provide a variety of regulatory 
sequences to eukaryotic genomes (66), and there are several examples of TE-derived 
insulators.  The best studied TE-insulator comes from the Drosophila gypsy element 
(46,76-78).  Gypsy is a long terminal repeat retrotransposon that contains an insulator 
sequence in its 5‟ untranslated region.  The gypsy insulator interacts with the suppressor 
of hairy wing [su(Hw)] and modifier of mdg4 [mod(mdg4)] proteins to block regulatory 
interactions between distal enhancer and proximal promoter sequences.  This same 
insulator can also protect transgenes from position effects indicating that it encodes 
chromatin barrier activity as well. 
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More recently, TE-derived insulator sequences have been discovered in 
mammalian genomes.  The short interspersed nuclear element (SINE) B1 has insulator 
activity that is mediated by the binding of specific transcription factors along with the 
insulator associated protein CTCF (79).  Another mouse TE, the SINE B2 element, serves 
as a developmentally regulated compound insulator, encoding both enhancer-blocking 
and chromatin barrier activity, at the growth hormone locus (56).  B2 is a tRNA-derived 
SINE, and the connection to tRNAs is intriguing given the fact that tRNA gene sequences 
have been shown to encode insulators in yeast (52,53,80,81), mouse (55) and human 
(33,82).  A survey of six mammalian species revealed that lineage-specific expansions of 
retrotransposons have contributed numerous CTCF binding sites to their genomes (83).  
A number of these TE-derived CTCF binding sites in the mouse and rat genomes are 
capable of segregating domains enriched or depleted for acetylation of histone 2A lysine 
5 (H2AK5ac), suggesting that they may encode insulator function.  Interestingly, this 
same analysis did not detect retrotransposon driven expansion of CTCF binding sites in 
the human genome.        
Despite the fact that human TEs have yet to be implicated as insulators, the 
genome is made up of a substantial fraction of TE sequences including numerous tRNA-
derived SINE retrotransposons with the potential to encode insulator function (84).  
Mammalian-wide interspersed repeats (MIRs) are an ancient family of TEs (85) that bear 
several features suggesting that they may serve as genome regulators in general and 
insulators in particular.  First of all, a number of non-coding MIR sequences were found 
to be highly conserved, indicative of some functional, presumably regulatory, role (86).  
Later, it was shown that MIRs are enriched for open chromatin sites (87), encode 
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regulatory RNAs (88), host gene promoters (89) and enhancers (90) and are also 
associated with tissue-specific expressed genes (91).  Finally, MIRs are tRNA-derived 
SINEs (92) and their sequences include recognizable regulatory motifs, such as the 
promoter B-box element, that are thought to be important for insulator activity. 
In light of these known MIR regulatory sequence characteristics, we sought to 
evaluate whether MIR elements can encode insulator activity in the human genome.  To 
do this, we employed a bioinformatics screen of genome sequence and functional 
genomic data to identify a subset of MIR sequences that possess insulator-like features.  
These features include the presence of intact B-box sequences, occupancy by RNA Pol 
III and the partitioning of active and repressive chromatin domains (Figure 4.1.A).  This 
procedure resulted in the identification of >1,000 putative MIR-derived insulator 
sequences, which were first validated computationally and experimentally and then 
evaluated with respect to a number of functional properties.    
Results 
Bioinformatic screen and validation 
We developed and applied a bioinformatic screen to search for human MIR 
sequences that may encode insulator activity (Figure 4.1.A).  To do this, we evaluated 
human genome sequence data along with functional genomic data from CD4
+
 T cells.  
CD4
+
 T cells were chosen owing to their importance as a model system for immunology 
and for the abundance of available functional genomic data that exist for this cell-type.  
The genome sequence data analyzed consisted of TE and gene annotations, and the 
functional genomic data included RNA-seq and microarray expression data along with 







Figure 4.1:  Bioinformatic screen and validation of MIR-insulators.  (A) Scheme of 
bioinformatic screen used to predict MIR-insulators.  (B) Spearman correlations for 
individual histone modification profiles upstream versus downstream of predicted MIR-
insulators.  (C) Heatmap showing Spearman correlations for pairs of histone modification 
profiles.   (D) Average (± standard error) CD4+ T cell expression levels of proximal 
genes from the active (grey) and repressive (black) sides of predicted MIR-insulators.  
(E) Average (± standard error) differences in gene expression levels for genes located on 






First, all MIR sequences in the human genome that contain intact B-boxes and are 
bound by RNA Pol III in CD4
+
 T cells were identified.  Then, these MIRs were evaluated 
for their ability to partition active versus repressive chromatin using a previously 
described approach (33) that segregates histone modifications associated with expressed 
(active) versus silent (repressive) genomic regions.  To do this, broad genomic 
distributions of 39 histone modifications, with 34 characterized as active and 5 
characterized as repressive, were evaluated in order to detect large contiguous regions 
(domains) of active and repressive chromatin.  The B-box containing and RNA Pol III 
bound MIR elements found to be located between adjacent active versus repressive were 
then selected for further analysis.  Finally, RNA-seq was used to further reduce the list of 
putative MIR-insulators to those that delineate high versus low expressed genomic 
regions.  This procedure resulted in the identification of 1,178 putative MIR-derived 
insulators across the human genome (Figure 4.1.A).    
The putative MIR-derived insulators were computationally validated with respect 
to their affects on chromatin and gene expression.  For chromatin, the putative insulators 
were evaluated for their ability to partition individual histone modifications and to 
delineate sets of modifications that have been previously characterized (18) as active 
versus repressive (Figure C.1).  ChIP-seq tag counts for all 39 histone modifications 
analyzed here are negatively correlated for the regions upstream versus downstream of 
the putative MIR-insulators (Figure 4.1.B and Table C.1), indicating that this set of MIRs 
partitions specific histone modification sites in the local chromatin environment.  In 
addition, when the histone modifications are considered as an ensemble, by clustering 
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their joint upstream versus downstream ChIP-seq profiles, active and repressive 
modifications can be seen to group together (Figure 4.1.C and Figure C.2).  This result 
indicates that the putative MIR-insulators identified here also delineate active versus 
repressive chromatin marks.  Consistent with this result, genes located proximal to the 
MIR-insulators in the active chromatin environment are expressed at higher levels than 
the genes located on the repressive side of the insulators (Figure 4.1.D and Figure C.3). 
We also evaluated the role that the putative MIR-insulators play in regulating 
tissue-specific expression by measuring the differences in expression levels, across 79 
human tissues, for genes that flank the insulators.  Genes that flank MIR-insulators show 
greater differences in expression, between the active and repressive sides of the 
insulators, in CD4
+ 
T cells than seen for the other human tissues (Figure 4.1.E and Figure 
C.4), consistent with a role for the insulators in establishing tissue-specific chromatin 
domains.  Taken together, the results of the bioinformatic analyses support the notion that 
human MIRs can serve as insulators and suggest that the putative MIR-insulators 
identified here encode chromatin barriers that function as tissue-specific regulators.    
Experimental validation 
We sought to experimentally validate the enhancer-blocking activity for a subset 
of the MIR-insulators predicted here using previously described human and zebrafish 
enhancer-blocking assays (EBAs) (56,79,93,94).  For the human EBA, a luciferase 
reporter construct transfected in human HEK 293 cells was used to evaluate both short 
(200 - 400 bp) and long (1000 – 1200 bp) sequences centered on three predicted MIR-
insulators (Table C.2).  All three MIR-insulators tested here showed enhancer-blocking 
activity comparable to the 5‟ HS4 positive control (Figure 4.2.A).  For the most case, 
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both short and long sequences show similar levels of enhancer-blocking activity.  The 
only exception was the long sequence from the chromosome 11 MIR-insulator, which 
showed slightly lower enhancer-blocking activity than both the positive control and the 
short sequence from the same locus.  This suggests the possibility of interference from 

















Figure 4.2:  Enhancer-blocking assays (EBAs) for predicted MIR-insulators.  (A) 
Human EBA.  Enhancer-blocking activity levels (fold-enrichment) are normalized 
relative to the empty vector.  Average enhancer-blocking activity levels (± standard error) 
for positive (5‟HS4 and II/III) and negative (II/III mutated) controls along with results for 
short and long sequences surrounding predicted MIR-insulators from chromosomes 1, 2 
and 11 are shown.  For each sequence analyzed, inserts were cloned upstream of the 
enhancer (negative control site) and between the enhancer and promoter (test site).  (B) 
Zebrafish EBA.  Positive (5‟ HS4) and negative (empty vector) control sequences along 
with short and long sequences surrounding predicted MIR-insulators from chromosomes 
1, 2 and 11 were inserted between the CNS enhancer and the somite promoter.  GFP 
expression in somites versus enhancers indicates relative enhancer-blocking activity.  (C) 
Enhancer-blocking activity in zebrafish is quantified as the average (± standard error) 




The same short and long MIR-insulator sequences were tested in a zebrafish EBA 
using a GFP reporter construct transiently transfected in embryos.  This EBA tests the 
ability of putative insulator sequences to block interaction of a central nervous system 
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(CNS) enhancer with a somite GFP promoter (Figure 4.2.B).  All MIR-insulator 
sequences tested show enhancer-blocking activity greater than seen for the 5‟ HS4 
positive control (Figure 4.2.C).  There are some differences between the short and long 
sequences, but they are not consistent across the tested sequences.  Taken together, the 
results of in these EBAs demonstrate that selected MIR-insulator sequences encode 
strong enhancer-blocking activity, which is conserved between cell-types and across 
species.   
MIR insulator chromatin features 
Having established the chromatin barrier and enhancer-blocking activity of 
predicted MIR-insulators, we performed a series of enrichment analyses to characterize 
the local chromatin environment at-and-around these insulators.  RNA Pol III occupancy 
levels peak at MIR-insulator sequences (Figure 4.3.A), which is consistent with the initial 
bioinformatic screen used for their identification.  Nevertheless, the distinct RNA Pol III 
peak at MIR-insulators differs from the previously observed broad genomic distribution 
of RNA Pol III binding (95) suggesting the possibility that MIR-insulators are activated 
via specific recruitment of RNA Pol III and possibly transcriptional activation.  In 
addition, the negative control, performed on a randomly selected set of B-box containing 
MIRs, shows that specific RNA Pol III binding is not a generic feature of MIRs across 
the genome.  RNA Pol II levels, on the other hand, increase steadily from the MIR-
insulator region into the flanking active chromatin environment (Figure 4.3.B), consistent 
with their role as barriers against the spread of repressive chromatin. 
Binding of the insulator-associated protein CTCF also peaks around MIR-
insulator sequences relative to flanking genomic regions and shows a strong enrichment 
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compared to the genomic background (Figure 4.3.C).  However, CTCF binding levels are 
slightly depleted right at the locations of the MIR-insulators, raising the possibility of co-
operative action between CTCF-independent MIR-insulator mechanisms and the CTCF 





Figure 4.3:  Enrichment of chromatin features around predicted MIR-insulators.  
8kb windows centered on predicted MIR-insulators were evaluated for the fold-
enrichment (compared to genomic background) of (A) RNA Pol III binding, (B) RNA 
Pol II binding, (C) CTCF binding and (D) levels of five histone modifications.  For each 
enrichment curve, a corresponding negative control (lower lines marked with crosses) is 





MIR-insulators show a characteristic histone modification signature with 
distinctive peaks of the H2AZ histone variant, H3K4me1, H3K4me2 and H3K9me1 
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(Figure 4.3.D).  Such peaked patterns can not be expected based on the approach used to 
detect putative MIR-insulators since the algorithm evaluates broad distributions of active 
versus repressive histone modifications over 100kb windows surrounding the MIRs.  
H3K4me3 levels peak adjacent to the locations of the MIR-insulators on the active 
chromatin side and remain high across the local active chromatin domain.  Most of these 
marks are associated with active chromatin and transcriptional initiation, suggestive of 
the recruitment of chromatin modifying complexes to MIR-insulators resulting in the 
local opening of chromatin and priming for gene expression.  Consistent with this 
possibility, MIR-insulators are much closer to the nearest gene transcription start site 
(TSS) on the active chromatin side than on the repressive side (Figure C.5).  H3K4me1 
modifications are often associated with enhancer sequences, raising the possibility of 
some mechanistic overlap between MIR-insulators and enhancers, as has been previously 
suggested (44).     
Tissue-specific chromatin barrier functions of MIR-insulators 
Human and zebrafish EBAs indicate that MIR sequences are likely to encode 
enhancer-blocking activity via conserved mechanisms (Figure 4.2), whereas 
computational validation of the MIR-insulator predictions suggest that MIR-insulator 
chromatin barrier activity is tissue-specific (Figure 4.1.E).  We sought to further evaluate 
the possible tissue-specific functional roles played by the MIR-insulators predicted here.  
To do this, we performed an analysis of the gene ontology (GO) and pathway (KEGG) 
annotations of the genes located on the active chromatin sides of the MIR-insulators.  
These genes are enriched for a number of GO functional categories related to T cell 
function including cell-cell interactions and immune signaling cascades (Figure 4.4.A).  
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Perhaps most strikingly, this analysis revealed that 21 genes found in the T cell receptor 
signaling pathway (KEGG: hsa04660) are located adjacent to MIR insulators on the 
active chromatin side (Figure 4.4.A, Figure 4.4.B and Figure C.6).  Among this list, there 
are several transmembrane receptor proteins, which mediate interactions with antigen-
presenting cells, including a co-located genomic cluster of two T cell co-stimulators 
(CD28 and ICOS) and the co-inhibitor CTLA4 (Figure 4.4.C).  The chromatin 
environment at this genomic cluster, along with the cell type-specific expression patterns 
of these three genes, exemplifies the T cell-specific regulatory function of the MIR-
insulator encoded barrier activity (Figure 4.4.D).  In CD4
+
 T cells, these three genes are 
flanked by pairs of MIR-insulators that surround an open and active chromatin 
environment (H3K4me3 and H3K36me3) to the exclusion of repressive chromatin marks 
(H3K27me3) in the adjacent regions.  This pattern stands in contrast to what is seen for 
GM12878 and K562 cells where the entire locus is marked by repressive chromatin.  
Accordingly, CD28, ICOS and CTLA4 are highly expressed in CD4
+
 T cells compared to 
GM12878 and K562 cells (Figure 4.4.D).  Similar cell type-specific distributions of 
chromatin and gene expression for MIR-insulators and their adjacent genomic regions are 
observed when the same histone marks and expression levels are compared for all 21 







Figure 4.4: T cell-specific functions of predicted MIR-insulators.  (A) Results of a 
gene ontology (GO) and pathway (KEGG) analysis of proximal genes on the active 
domain side of MIR-insulators.  P-values (-log10 normalized) are shown for the KEGG 
(red), GO biological process (orange), GO molecular function (blue) and GO cellular 
component (purple) analyses; the grey line corresponds to P=0.05.  (B) List of 21 T cell 
receptor signaling pathway genes located on the active domain side proximal to MIR-
insulators.  (C) Portion of the T cell receptor pathway showing membrane receptors that 
mediate T cell stimulation via antigen presenting cells.  (D) Expression levels and the 
chromatin environment across a genomic cluster of three T cell receptor genes – CD28, 
CTLA4 and ICOS (blue gene models) – and their co-located MIR-insulators (purple bars) 
are shown for CD4+ T cells, GM12878 and K562.  Relative gene expression levels (high-
red to low-green) are shown coincident with the gene models.  Genomic distributions of 







We expanded the tissue-specific chromatin and expression analysis to include all 
MIR-insulators predicted here.  To do this, we first classified MIR-insulators as cell-type 
specific based on the relative distributions of chromatin marks across MIR-insulators in 
CD4
+
 T cells versus GM12878 and K562 cells.  681 out 1,178 (58%) of predicted MIR-
insulators show skewed distributions of active versus repressive marks in CD4
+
 T cells, 
with divergent peaks on opposing sides of the MIR-insulators, compared to relatively flat 
distributions of the same histone marks in GM12878 and K562 cells (Figure 4.5A-C).  
Accordingly, these tissue-specific MIR-insulators have proximal genes on the active 
domain side that are expressed at higher levels in CD4
+
 T cells than the same genes in 
GM12878 and K562 (Figure 4.5.D).  Furthermore, these MIR-insulators separate pairs of 
genes, on the active versus repressive chromatin sides of the insulators, that have greater 
differences in their levels of expression in CD4
+
 T cells than seen for the same pairs of 
genes in GM12878 and K562 (Figure 4.5.E).  The 42% of MIR-insulators that do not 
show evidence of tissue-specific function may have broader activity reflecting chromatin 
boundary establishment earlier in development.  It is also possible that additional MIRs 
not detected in our bioinformatic screen, e.g. those that lack intact B-boxes or those do 
not bind RNA Pol III, may also serve as insulators in CD4
+







Figure 4.5: Cell-type specific chromatin barrier activity and gene regulation by 
MIR-insulators.  ChIP-seq fold enrichment levels around tissue-specific MIR-insulators 
are shown for (A) H3K4me3, (B) H3K36me3 and (C) H3K27me3 in CD4+ T cells 
(black), GM12878 cells (red) and K562 (orange) cells.  Insets show the average 
differences (± standard error) between the active versus repressive domains surrounding 
MIR-insulators for the marks and cells.    (D) Average gene expression levels (± standard 
error) are shown for genes located in the active domain side proximal to MIR-insulators.  
(E) Average (± standard error) differences in the gene expression levels for genes located 
on the opposite sides of individual MIR-insulators.  For all bar plots, significance of the 






MIRs are relatively ancient and conserved TEs, i.e. formerly selfish genetic 
elements, that have been co-opted to provide a variety of regulatory sequences to their 
host genomes.  Together with their conservation and regulatory capacity, the tRNA-
derived sequence features of MIRs suggested to us that they might help to organize 
human chromatin via the provisioning of insulator elements.  Therefore, we screened the 
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human genome for putative MIR-insulators and attempted to validate their activity using 
a combined computational and experimental approach.  The results of our analysis 
suggest that numerous MIR sequences serve as insulators across the human genome.  
These predicted MIR-insulators show evidence of both chromatin barrier and enhancer-
blocking activity.  Interestingly, while the chromatin barrier activity of the MIR-
insulators appears to be cell type-specific (Figure 4.1.E, Figure 4.4 and Figure 4.5), the 
mechanisms underlie MIR‟s enhancer-blocking activity are seemingly conserved between 
cell-types and between species (Figure 4.2).  This may be attributed to the fact that MIR 
sequences in isolation possess an innate capacity to provide enhancer-blocking activity 
via the interaction with conserved protein factors, but in situ MIRs interact with cell-type 
restricted factors to yield a more narrow and specific range of activity.  Given that the 
EBAs were performed with minimal (<1200 bp) constructs, it may be the case that 
synergistic binding of sites outside the MIR-insulators help to provide cell-type specific 
barrier activity.    
The MIR-insulators identified here have a distinct local chromatin environment 
(Figure 4.3) that may yield some clues as to their mechanisms of action.  For example, 
while RNA Pol II and RNA Pol III CD4
+
 T cell binding profiles are highly correlated 
across the human genome (95), their patterns at-and-around MIR-insulators are quite 
distinct.  RNA Pol III occupancy levels peak right at the MIR-insulators, whereas RNA 
Pol II levels steadily increase from the MIR-insulators into the adjacent active chromatin 
domains.  This suggests the possibility that RNA Pol III is specifically recruited to MIR-
insulators to help establish their activity, thus priming the adjacent chromatin for opening 
and transcriptional activity as reflected by the increasing RNA Pol II levels.  The histone 
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modification profiles around MIR-insulators are consistent with this model.  There are 
clear local peaks of modifications right at the MIR-insulators, such as seen for H3K4me1 
and H3K4me2, but these same marks of open chromatin are also maintained at relatively 
higher levels in the adjacent active domains.  H3K4me3 shows a similar pattern, but its 
peak is shifted further into the active domain and it is maintained at higher levels through 
this domain.  Thus, there may be a wave of progressive methylation of the H3K4 position 
starting at the MIR-insulator locations and continuing with the addition of methyl groups 
into the active domain, similar to what we observed previously for human chromatin 
barriers(33).     
The location of MIR-insulators relative to proximal gene promoters also sheds 
some light on their mechanism of action.  MIR-insulators are located much closer to the 
promoters of the genes that are located on the active side of the insulator compared to the 
genes located on the repressive side (Figure C.5).  This suggests that MIR-insulators are 
not only located in such a way to protect proximal promoters from the encroachment of 
repressive chromatin, but also restrict interactions with promoters to only those enhancers 
that are located nearby or within genes.  This scenario can be illustrated by cluster the co-
located T cell receptors – CD28, CTLA4 and ICOS – each of which is flanked by a pair 
of MIR-insulators (Figure 4.4.D).  This apparent restriction to local enhancers would 
seem to be odds with the textbook definition of enhancers as regulatory elements that 
exert their effects over long ranges.  However, recent genome-wide analyses of chromatin 
reveal that gene bodies are enriched for enhancer elements (7,25,28) and these local 
regulatory sequences may be largely responsible for cell-type specific expression. 
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TE-derived insulators have previously been associated with CTCF binding events 
(83).  The dependence of MIR-insulators on the vertebrate insulator protein CTCF is far 
from clear based on the results of our analysis.  While there is a clear enrichment of 
CTCF binding in the local proximity of MIR-insulators (Figure 4.3.C), only 52 of 1,178 
(4.5%) MIR-insulator sequences predicted here are actually bound by CTCF in CD4
+
 T 
cells.  In fact, for many of the MIR-insulators, CTCF binding appears to peak in the 
genomic regions just adjacent to the elements.  This suggests the possibility of 
cooperativity between MIR sequences and the local genomic context in establishing 
insulator activity.  However, if this were indeed the case, one would expect that the 
longer insulator sequence inserts used in the EBA constructs would invariably yield 
higher enhancer-blocking activity and this was clearly not the case (Figure 4.2).  These 
results raise the possibility that MIR-insulators function in a largely CTCF independent 
manner. 
Many questions as to the specific mechanisms underlying MIR-insulator activity 
remain to be answered.  For example, while the compound insulator activity of the mouse 
tRNA-derived SINE B2 is related to the transcriptional activity of the element (56), it is 
not clear if the same can be said for MIR-insulators.  Furthermore, many of the protein 
factors that interact with MIR-insulators remain to be elucidated.  Nevertheless, the 
finding that numerous MIRs across the human genome can provide insulator activity 
raises intriguing possibilities.  In particular, when their repetitive nature is considered 
together with their role in organizing chromatin, it suggests a possible mechanism for the 
establishment of cell-type specific regulatory networks by TEs as long ago envisioned by 
McClintock (96) and Britten and Davidson (97).   
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Materials and methods 
Genomic and functional genomic data sets  
The human genome reference sequence (NCBI build 36.1, UCSC version hg18) 
was analyzed with respect to the locations of MIR TE sequences and NCIB RefSeq gene 
locations using the UCSC Genome Browser „RepeatMasker‟ and „RefSeq Genes‟ tracks 
respectively.  ChIP-seq data (3,18) were used to characterize the genomic locations of 38 
histone modifications and one histone variant in CD4
+
 T cells.  ChIP-seq data were used 
to characterize the genomic locations of RNA Pol II, CTCF (3) and RNA Pol III (95) 
binding sites in CD4
+
 T cells.  ChIP-seq data from the ENCODE consortium were used to 
characterized the locations of three histone modifications in GM12878 and K562 cells 
(7,98).  Microrray data were used to characterized gene expression levels across 79 
human tissues (99), including CD4
+
 T cells, along with GM12878 and K562 (100,101).  
Microarray signal intensity values were normalized using the z-transformation in order to 
compare relative expression levels across tissues and microarray platforms.  RNA-seq 
data from CD4
+
 T cells (95) were used to characterize genome expression levels.  
Bioinformatic prediction and validation of MIR-insulators 
Human genome MIR sequences (candidate insulators) were screened through a 
series of filters to identify a final set of predicted MIR-derived insulators (Figure 4.1.A).  
The final set of predicted MIR-insulators (n=1,178) contains the following set of 
properties: intact B-box promoter sequences, occupancy by RNA Pol III, segregation of 
active versus repressive chromatin domains and segregation of expressed versus silent 
genomic regions.  The ability of the predicted set of MIR-insulators to segregate 
individual histone modifications and to group active and repressive modifications 
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together were computationally validated using correlation analysis of ChIP-seq data for 
the 39 CD4
+
 T cell histone modifications.  Details of the MIR-insulator computational 
validation procedure can be found in the Figure C.1.   
Enhancer blocking assays (EBAs) 
Human EBAs were performed as previously described (56,102) using the pELuc 
vector and transient transfection HEK 293 cells.  Selected MIR-insulator sequences were 
cloned upstream (negative control) or between (test) enhancer and promoter sequences 
and enhancer-blocking activity was measured based on relative levels of luciferase 
expression.  The 5‟ HS4 insulator from the chicken beta-globin locus and the minimal 
insulator sequence motifs (II/III) from this same element were used as positive controls in 
this assay.  Mutated II/III sequence motifs, incapable of binding CTCF, were used as 
negative controls.  Three replicates were performed for each EBA.   
Zebrafish EBAs were performed as previously described (103) using a Tol2 
transposon-based vector and transient transfection of zebrafish embryos.  Selected MIR-
insulator sequences were cloned between a central nervous system (CNS) enhancer and a 
promoter that drives somite expression, and enhancer-blocking activity was measured 
based on relative levels of somite/CNS GFP expression.  The 5‟ HS4 insulator from the 
chicken beta-globin locus was used as a positive control in this assay; an empty vector 
was used as a negative control.  For each putative MIR-insulator sequence tested, 41-46 
replicates were assayed to control for chromatin position effects.     
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GENOME-WIDE PREDICTION AND ANALYSIS OF HUMAN 





Boundary elements partition eukaryotic chromatin into active and repressive 
domains, and can block regulatory interactions between domains.  Boundary elements act 
via diverse mechanisms making accurate feature-based computational predictions 
difficult.  Therefore, we developed an unbiased algorithm that predicts the locations of 
human boundary elements based on the genomic distributions of chromatin and 
transcriptional states, as opposed to any intrinsic characteristics that they may possess.  
Application of our algorithm to ChIP-seq data for histone modifications and RNA Pol II 
binding data in human CD4
+
 T cells resulted in the prediction of 2,542 putative 
chromatin boundary elements genome-wide.  Predicted boundary elements display two 
distinct features: first, position-specific open chromatin and histone acetylation that is 
coincident with the recruitment of sequence-specific DNA binding factors such as CTCF, 
EVI1 and YYI, and second, a directional and gradual increase in histone lysine 
methylation across predicted boundaries coincident with a gain of expression of non-
coding RNAs, including examples of boundaries encoded by tRNA and other non-coding 
RNA genes.  Accordingly, a number of the predicted human boundaries may function via 
the synergistic action of sequence-specific recruitment of transcription factors leading to 
non-coding RNA transcriptional interference and the blocking of facultative 
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heterochromatin propagation by transcription-associated chromatin re-modeling 
complexes.  
Introduction 
Eukaryotic chromosomes are functionally organized into alternating active and 
repressive chromatin domains, referred to as euchromatin and heterochromatin 
respectively (64,104).  Active chromatin domains are characterized by histone 
modifications that facilitate gene expression via the opening of chromatin, which 
provides transcription factors access to genomic DNA, whereas repressive domains are 
enriched with histone modifications that yield more tightly compact and less accessible 
chromatin leading to the repression of gene expression (1,2,105-109).  Accordingly, the 
establishment and maintenance of distinct chromatin domains has important implications 
for gene regulation specific to cellular development and function (110,111). 
The organization of eukaryotic chromatin into functionally distinct domains 
implies the existence of chromatin partitioning elements that can be used both to 
delineate active euchromatic and repressive heterochromatic domains, while preserving 
their structural integrity, and to prevent regulatory cross-talk between different domains 
(43,44,57,75).  Such chromatin partitioning elements do in fact exist and they are known 
as „boundary elements‟ (46,56,78).  Boundary element functionality is characterized by 
two fundamental properties: 1) the ability to protect from chromosomal position effects 
by acting as barriers against the self-propagation of repressive chromatin (46,80,112) and 
2) the ability to insulate or block regulatory interactions between distal enhancers and 
proximal gene promoters (57,113,114).  Some boundary elements are able to act both as 
chromatin barriers and enhancer blocking insulators (56,115).  Boundary elements that 
72 
 
are cell-type specific help to establish alternating facultative, as opposed to constitutive, 
euchromatic and heterochromatic domains.  
Known boundary elements are diverse, and several different mechanisms of 
boundary element activity have been uncovered.  First, fixed boundary elements consist 
of specific DNA sequences and their associated proteins, which establish boundaries with 
well defined positions.  Such precisely located boundaries are thought to form discrete 
physical barriers that partition distinct chromatin and/or regulatory domains.  For 
example, the HS4 boundary element found upstream of the chicken β-globin locus is 
bound by the CCCTC-binding factor (CTCF), a well known vertebrate insulator 
associated protein with demonstrated enhancer blocking activity (49,116).  The scs/scs‟ 
elements in Drosophila provide fixed boundaries at the heat-shock domain locus 
(112,114,117), and the chromatin barrier activity of the scs/scs‟ boundaries is dependent 
upon the binding of two protein factors Zw5 and BEAF (118).     
Second, there are variable boundary elements that do not occupy specific DNA 
sequences or genomic locations.  These variable boundaries are thought to be established 
and maintained through a dynamic balance of collisions between opposing chromatin 
modifying enzyme complexes responsible for the formation of euchromatin on one side 
of the boundary and heterochromatin on the other (119,120).  For example, the 
phenomenon of position effect variegation (PEV) in Drosophila can be attributed to 
variable boundary elements (44,121).  PEV refers to the variegated expression of genes 
located between adjacent euchromatic and heterochromatic domains.  PEV occurs due to 
the changing locations of variable boundaries between cells, which result in genes being 
located in alternating euchromatic or heterochromatic environments in different cells.   
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Third, boundary element activity can depend upon transcriptional interference 
from small non-protein-coding transcriptional units, such as tRNA genes in yeast 
(52,53,74,80,81) or tRNA-derived SINE retrotransposons in mouse (56,79).  Boundary 
elements that function via transcriptional interference contain specific sequence features 
needed to recruit transcription factors (e.g. the Pol II and Pol III machineries), and they 
may also provide a physical barrier to the propagation of heterochromatin via 
nucleosomal gaps close to transcription start sites.  These nucleosomal gaps may also 
serve as entry sites for chromatin remodeling complexes that help to establish the 
boundaries (43,53).  
Thus, many of the currently known boundary elements have been defined 
functionally, based on experimental confirmation of their activity, rather than 
categorically based on the presence of well defined features.  Indeed, as detailed above, 
there are diverse mechanisms that underlie boundary element activity and no common 
sequence or protein features that unite all known boundaries.  This lack of common 
boundary element features makes comprehensive prediction of boundaries difficult.  To 
date, boundary element prediction methods have relied on specific features to identify 
mechanistically coherent subsets of boundaries.  For example, genome-wide distributions 
of CTCF binding sites considered together with chromatin domain borders have been 
used to infer the locations of putative fixed boundaries (3,122).  This feature-based 
approach to boundary element prediction may overlook boundaries that function via 
diverse and possibly as yet unknown mechanisms. 
Recently, a number of genome-wide maps of histone modifications have been 
computationally analyzed in order to describe chromatin architecture in terms of the 
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distribution of distinct domains within and between cell types.  For instance, studies in 
Drosophila melanogaster (25,123), Caenorhabditis elegans (15) and human (6,7) have 
characterized the genomic distributions of euchromatic and heterochromatic domains at 
high levels of resolution.  The ability to characterize chromatin domain distributions in 
this way suggests that it should also be possible to more precisely define the locations of 
putative chromatin boundaries between domains along with their local properties.  To 
address this issue here, we employed a computational analysis of histone modification 
maps in human CD4
+
 T cells.  To date, CD4
+
 T cells represent the single best 
characterized system for studying chromatin architecture as there exist genome-wide 
maps for 38 histone modifications and one histone variant (3,18).  The existence of 
multiple (five) repressive modifications, in particular, is a unique aspect of this data set 
that provides increased resolution for delineating active versus repressive domains.  
Furthermore, experimentally characterized genome-wide maps of chromatin accessibility 
(DNase I hypersensitive sites), binding sites for RNA Pol II and Pol III as well as several 
other protein factors exist for CD4
+
 T cells along with RNA-seq data for genome 
expression.   
The goal of this study was to take advantage of the detailed genome-wide 
chromatin maps that exist for CD4
+
 T cells in order to predict and analyze a collection of 
putative human boundary elements that is unbiased with respect to the mechanisms of 
boundary activity.  Such a set of predicted boundary elements could help to prioritize 
experimental interrogation of boundaries and further define the scope of possible 
boundary element mechanisms.  To this end, we developed a boundary element 
prediction algorithm that does not rely on any previously characterized features of 
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boundary element sequences, such as the binding of specific protein factors (e.g. CTCF), 
the presence of tRNA or tRNA-derived sequences or the expression of non-coding 
RNAs.  Rather, our approach defines the genomic positions of putative boundaries in 
cell-type specific manner based solely on the locations of transition points between 
facultatively active (euchromatic) and repressive (heterochromatic) domains, along with 
the distributions of Pol II binding sites.  We chose this objective approach to avoid 
biasing our boundary element predictions with respect to a limited set of previously 
known features, and more importantly, to allow for the opportunity to discover boundary 
elements that may operate via novel, previously unreported mechanisms of action.  
Boundary element prediction proceeded in two steps.  First, we defined euchromatic and 
heterochromatic domains based on the distributions of active versus repressive histone 
modifications, and the regions between adjacent domains were taken as possible locations 
for boundary elements.  Second, the regions between chromatin domains were further 
analyzed with respect to the distributions of Pol II binding sites to more precisely locate 
putative boundaries. 
Application of this two-stage chromatin boundary element prediction algorithm to 
human CD4
+
 T cell chromatin data resulted in the prediction of 2,542 cell-type specific 
boundary elements genome-wide.  The functional relevance of the predicted boundaries, 
with respect to facultative chromatin and cell-type specific expression, was supported by 
the finding that pairs of genes immediately flanking the boundaries are more divergently 
expressed in CD4
+
 T cells than in other human cells.  Feature analysis of the predicted 
human boundaries suggests the possibility of several novel and distinct modes of action: 
1) predicted boundaries show a distinct local chromatin environment including peaks of 
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open chromatin marked by enrichment for numerous histone acetylations.  These results 
suggest that the establishment of boundaries involves the local action of specific 
chromatin remodeling proteins, 2) while many of the predicted boundaries are shown to 
be bound by the well known insulator protein CTCF, there are a number of boundaries 
that may function in a CTCF-independent manner via the binding of protein factors that 
are known to function in chromatin remodeling but were not previously implicated in 
boundary activity, e.g. EVI1 and YY1, 3) a number of predicted boundaries show 
evidence for the action of transcriptional interference including examples of putative 
tRNA derived boundaries.  tRNA genes were previously shown to function as boundaries 
in yeast (52,53,80,81) but these are the first examples of putative tRNA derived 
boundaries in human.   
Materials and methods 
Datasets of histone modifications and Pol II binding in CD4+ T cells 
We used publicly available genome-wide ChIP-seq data for 38 histone 
modifications and one histone variant (H2A.Z) defined in human CD4
+
 T cells (3,18). 
These 39 histone modifications are classified into active histone modifications and 
repressive histone modifications, based on previous results (18), for use in chromatin 
domain prediction.  Active modifications are positively correlated with gene expression 
levels and are known to mark euchromatic genomic regions, whereas repressive 
modifications are negatively correlated with expression levels and mark heterochromatic 
domains.  The 34 active modifications used here are: H2BK5ac, H2BK12ac, H2BK20ac, 
H2BK120ac, H2AK5ac, H2AK9ac, H2AZ, K3K4ac, H3K9ac, H3K14ac, H3K18ac, 
H3K23ac, H3K27ac, H3K36ac, H4K8ac, H3K12ac, H4K5ac, H4K16ac, H4K91ac, 
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H2BK5me1, H3K4me1, H3K4me2, H3K4me3, H3K9me1, H3K27me1, H3K36me1, 
H3K36me3, H3K79me1, H3K79me2, H3K79me3, H3R2me1, H3R2me2, H4K20me1 
and H4R3me2.  The 5 repressive modifications are: H3K9me2, H3K9me3, H3K27me2, 
H3K27me3 and H4K20me3.  Genome-wide ChIP-seq data for Pol II binding in CD4
+
 T 
cells was also obtained from Barski et al. 2007.  
General scheme of chromatin boundary element prediction algorithm 
In order to predict chromatin boundary elements in CD4
+
 T cells, we designed a 
two-stage algorithm (Figure 5.1.A). First, we employed active versus repressive histone 
modification distribution information to define the locations of large-scale euchromatic 
and heterochromatic domains respectively (Figure 5.1.B).  Regions in transitions (RIT) 
between adjacent euchromatic and heterochromatic domains are taken as possible 
locations containing chromatin boundary elements.  Second, we predicted the specific 
locations of boundary elements using Pol II binding inside RITs.  Boundary elements 
were taken as 8kb windows flanking the precise transition points between high versus 
low Pol II binding regions.  Only RITs with one such Poll II transition point were 
considered to contain unambiguous boundary elements.  Details for each stage of the 







Figure 5.1: Boundary element prediction algorithm scheme.  A: Pipeline of the 
boundary element prediction algorithm.  B: Scheme of domain prediction: repressive 
modifications (R) and active modifications (A) at each genomic site are transformed to 
positive or negative scores.  A maximal-segment algorithm is then applied on the score 
strings to locate contiguous regions with local maximal cumulative scores; such regions 
correspond to euchromatic or heterochromatic domains.  C: Scheme of the hidden 
Markov model for boundary element prediction.  The two hidden states are 
heterochromatin and euchromatin.  Each state is characterized by distinct emission 




Domain localization with a maximal-segment algorithm 
Histone modifications were characterized as active versus repressive based on 
their correlation with gene expression levels as previously described (18).  All active 
modifications were then considered together as a single set for subsequent analysis as 
were all repressive modifications.  In order to infer heterochromatic domains, we set a 
positive score for each genomic location which has repressive histone modification ChIP-
seq tags and a negative score for each location with active modification tags.  The tag 
counts of repressive and active modifications were further classified as small (<= 8 tags), 
medium (>8 tags and <=15 tags) and large (>15 tags).  Based on Karlin‟s theorems (72), 
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s , where i ={repressive, 
active} and j ={small, medium, large}.  ijp  represents the estimated frequency of the 
specific kind of sites in real heterochromatin domains, and ijq  represents the genomic 
background frequency of the specific kind of sites.  Intuitively, in heterochromatic 
domains, the frequency of repressively modified sites is higher than the genomic 
frequency of repressively modified sites and the corresponding scores are positive and 
larger for sites with more tags.  Likewise, the scores for actively modified sites are 
negative.  We use the peri-centromeric regions to estimate ijp , since peri-centromeric 
regions are believed to be heterochromatic regions.  Peri-centromeric regions are defined 
as the regions on both sides of centromeres extending to the most proximal gene as 
previously described (124).  After the scoring step, we applied the maximal-segment 
algorithm (73) to detect contiguous genomic regions with local maximal cumulative 
scores.  Such contiguous regions represent domains that are enriched with repressive 
histone modifications, i.e. heterochromatic domains (Figure 5.1.B).  As previously 
suggested (64), we removed the candidate heterochromatic domains that are <10kb.  This 
cut-off was chosen to reflect that fact that domains, by definition, are thought to be broad 
and widely spread, and relatively short genomic regions <10kb are more likely to 
represent discrete regulatory elements than bona fide domains.  The remaining inferred 
heterochromatic domains were used in subsequent steps. 
In order to infer euchromatic domains, we set positive scores for actively 
modified sites and negative scores for repressively modified sites, and the other steps 
were the same as described for inference of heterochromatic domains.  As with 
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heterochromatic domains, predicted euchromatic domains <10kb were eliminated from 
further consideration.  In order to estimate the frequency of actively modified sites in real 
euchromatic domains, we used the histone modification data for the top 5% of genes that 
are most highly expressed in CD4
+
 T cells (99) assuming those genes must be inside 
euchromatic regions. 
After obtaining heterochromatic domains and euchromatic domains in this way, 
we define a list of RITs between adjacent heterochromatic and euchromatic domains.  All 
possible boundary elements should reside within RITs, but it is not necessary that every 
RIT contains a boundary element.  The next step in the algorithm narrows down these 
RITs to more precisely define the location of putative boundary elements. 
Boundary element localization with a hidden Markov model 
In order to more accurately predict specific chromatin boundary element locations 
within RITs, we took advantage of the fact that euchromatic regions have higher Pol II 
binding signal levels than heterochromatic regions.  We built a two-state hidden Markov 
model (HMM) on Pol II binding data, and employed the Viterbi algorithm to find the 
most possible hidden state chain (Figure 5.1.C).  The two states in this chain are 
heterochromatin and euchromatin respectively.  The emission probabilities of the Pol II 
signal in euchromatic regions are estimated based on Pol II data in genes which are the 
top 5% most highly expressed in CD4
+
 T cells, and the emission probabilities of Pol II 
signal in heterochromatic regions are estimated based on Pol II data in genes which are 
not expressed (the lowest 5%).  The total size of heterochromatic domains is denoted as 
1s  and the total size of euchromatic domains as 2s .  The total size of RITs that go from 
heterochromatin to euchromatin is denoted as 12t , and the total size of RITs that go from 
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euchromatin to heterochromatin as 21t .  Then the transition probability from 
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After running the Viterbi algorithm over all RITs, we recorded the most probable 
hidden state chains for each RIT.  Transition points from one state to the other were taken 
as possible boundary element locations.  To avoid bivalently modified regions and to 
eliminate small scale variations in Pol II binding, boundary elements were only predicted 
for RITs that show a single transition point in the hidden state chain.  Since boundary 
elements may be expected to contain a combination of multiple regulatory elements 
around the precise transition points, putative boundary elements were taken as 8kb 
regions around the exact transition points.  
DNase I hypersensitivity analysis 
Genome-wide DNase I hypersensitivity data in human CD4
+
 T cells were taken 
from (4). The genomic locations of DNase I hypersensitive sites are transformed to 
NCBI36/hg18 using the UCSC Genome Browser program Liftover (70,125).  To check 
whether the predicted boundary elements are more DNase I hypersensitive than flanking 
regions on average, we extended the predicted boundary elements by 8kb upstream and 
downstream and divided the extended regions into 1kb non-overlapping bins. For each 
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bin, we calculated the average DNase I hypersensitive scores and normalized them by the 
genomic average DNase I hypersensitive scores. 
Histone modification signature analysis 
Tag counts for each individual histone modification were computed for predicted 
boundary elements extended by 8kb upstream and downstream.  Extended regions were 
divided into 1kb non-overlapping bins, and for each bin, the average tag counts are 
normalized by genomic averages.  
Analysis of CTCF binding 
Genome-wide ChIP-seq data for CTCF binding in human CD4
+
 T cells were 
taken from (3).  We only considered locations with more than 5 tags as reliable CTCF 
binding sites.  To check whether predicted boundary elements have higher affinity to 
CTCF binding than flanking regions on average, we extended the predicted boundary 
elements by 8kb upstream and downstream and divided the extended regions into 1kb 
non-overlapping bins.  For each bin, we calculated the average CTCF tag counts and 
normalized them by the genomic average CTCF tag count for 1kb regions. 
TFBS analysis 
In order to look for putative protein factors associated with predicted chromatin 
boundary elements, we used the “TFBS Conserved” track from the UCSC Genome 
Browser.  We gathered those computationally predicted conserved TFBS (with Zscore 
above 1.96) inside predicted boundary elements.  For each transcription factor, we 
counted the number of its appearance within boundary elements and statistically tested 
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whether the specific transcription factor is significantly associated with boundary 
elements using the hypergeometric test.  
Boundary element transcription analysis 
RNA-seq data of transcription in human CD4
+
 T cells were taken from (95).  We 
extended the putative chromatin boundary elements by 8kb upstream and downstream 
and divided them into 1kb non-overlapping bins.  We calculated the average non-protein-
coding RNA-seq tag counts for each bin and normalized them by the genomic average 
tag counts.  The data was then log2 transformed.  Predicted boundary elements were 
classified into two groups: boundaries containing RNA genes and boundaries without 
RNA genes, and the above calculations were done on the two groups of boundaries 
separately.  The annotations of RNA gene locations are from the “RNA gene” track 
(126,127) on UCSC Genome Browser. 
Gene expression analysis 
Gene expression profiles were taken from (99).  For genes located within 
predicted euchromatic domains and heterochromatic domains, we calculated their 
average expression levels in human CD4
+
 T cells.  For each predicted boundary element, 
we took the two genes most proximal to it on the two opposite sides (the euchromatic 
side and the heterochromatic side) and calculated the expression differences between 
these pairs for CD4
+





Gene function annotations 
Gene Ontology analysis and KEGG pathway analysis were performed using 
MSigDB (128,129) for predicted euchromatic domains with high gene densities (> 1 
gene/20 kb). 
Results 
Datasets and chromatin boundary element prediction algorithm 
In recent years, a substantial body of data detailing the chromatin structure of 
eukaryotic genomes has been accumulated.  For the human genome in particular, there 
are now genomic maps with experimentally characterized locations of numerous histone 
modifications as well as binding sites for a variety of proteins.  Such data provide 
opportunities for the discovery of novel chromatin related regulatory elements across the 
genome.   
Human CD4
+
 T cells represent one of the best characterized systems for the 
genome-scale analysis of chromatin.  Keji Zhao and colleagues have used chromatin 
immunoprecipitation followed by high-throughput sequencing experiments (ChIP-seq) to 
generate genome-wide maps for 38 histone modifications and one histone variant 
(H2A.Z), CTCF binding, Pol II binding and Pol III binding (3,18,95).  Chromatin 
accessibility in CD4
+
 T cells has been evaluated genome-wide using DNase I 
hypersensitivity assays coupled to high-throughput sequencing (4), and genome-wide 
CD4
+
 T cell expression levels have been determined using microarray and RNA-seq 
technologies (95,99). 
We took advantage of the existence of these genome-scale chromatin datasets to 
facilitate the discovery of boundary elements in the human genome.  The goal of this 
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work was to provide a comprehensive list of likely boundary element candidates, and 
then to evaluate the features of these putative boundaries with respect to possible 
mechanisms of action.  We designed a two-stage algorithm to predict the locations of 
putative boundary elements (Figure 5.1.A).  In the first stage, we defined the locations of 
large-scale active (euchromatic) and repressive (heterochromatic) chromatin domains 
based on the genomic distributions of active and repressive histone modifications.  The 
histone modifications analyzed here were characterized active or repressive as previously 
described (see Materials and Methods) (18).  For each genomic position, a specific score 
(negative or positive) was assigned according to the relative abundance of active or 
repressive modifications.  A maximal-segment algorithm was then applied to the 
resulting string of scores to locate contiguous genomic regions with maximal local 
cumulative scores (Figure 5.1.B).  The maximal-segment algorithm was chosen because 
it can detect such contiguous regions over variant lengths, and it is robust to small scale 
stochastic noise in the ChIP-seq data.  The maximal-segment algorithm also worked well 
here because the parameters that define the relative negative or positive scores can be 
directly estimated from the ChIP-seq data.  Further details on our maximal-segment 
algorithm for domain detection can be found in the Materials and Methods section (see 
Domain localization with a maximal-segment algorithm).   
We searched for chromatin boundary elements that reside within regions between 
adjacent euchromatic and heterochromatic domains – hereafter referred to as regions in 
transition (RITs).  However, it should be noted that not all RITs will necessarily contain 
discretely located boundary elements.  For instance, some RITs may contain regions with 
fuzzy patterns of active and repressive modification distributions that would not allow for 
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precise delineation of boundary element locations.  Such fuzzy patterns may represent 
boundaries that act via PEV related mechanisms, owing to different boundary locations 
among heterogeneous cell populations, and these imprecisely located boundaries will not 
be detected by our method.  Furthermore, because the sizes of RITs can be relatively 
large (>50kb) in some cases, a method is needed to narrow down the genomic regions 
where predicted boundary elements can be located.  In light of both of these issues, we 
developed a second stage of the algorithm that uses a hidden Markov model (HMM) of 
Pol II binding distributions along RITs in order to more precisely locate boundary 
elements (Figure 5.1.C).  This approach is based on the rationale that euchromatin is 
transcriptionally active, whereas heterochromatin is largely transcriptionally silent.  
Accordingly, euchromatin is expected to have higher levels of Pol II binding, and 
heterochromatin is expected to have lower levels of Pol II binding.  Furthermore, Pol II 
protein complexes are known to associate with proteins that have acetyltransferase and/or 
chromatin re-modeling functions (130).  Thus, boundary elements are expected to be 
located in genomic regions with particularly sharp transitions between low and high Pol 
II binding; HMMs are ideal for delineating such abrupt transitions. 
HMMs were used to model RITs by predicting the facultative chromatin state – 
euchromatin or heterochromatin – for each genomic site that best explains the Pol II 
binding distribution along each RIT.  To do this, the Viterbi algorithm was used to infer 
the most probable chromatin state chain along the RITs based on Pol II binding emission 
probabilities and chromatin state transition probabilities (Figure 5.1.C).  Details on the 
HMM we used for boundary element localization can be found in the Materials and 
Methods section (see Boundary element localization with a hidden Markov model).  
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After obtaining the most probable hidden state chains of euchromatin and 
heterochromatin, we removed RITs that contain more than one transition point between 
the two chromatin states, since these represent ambiguously located boundaries.  
Sequence features of the remaining RITs are summarized in Table D.1.  For RITs with 
single chromatin state transition points, we take 8kb regions centered on those transition 
points as putative boundary element regions.  The 8kb window size was chosen to strike a 
balance between the utility of precisely locating predicted boundary elements and the 
biological reality that boundary element activity may be spread over multiple adjacently 
located regulatory elements.  
Chromatin domain localization 
In the first stage of the algorithm (Figure 5.1.B), we predicted the locations of 
large-scale active and repressive chromatin domains, i.e. facultative euchromatic and 
heterochromatic regions.  An example of several adjacent euchromatic and 
heterochromatic domains on chromosome 2 can be seen in Figure 5.2.  The predicted 
euchromatic domains are enriched with the active histone modification H3K79me1, and 
the predicted heterochromatic domains are enriched with the repressive modification 
H3K27me2.  The same pattern can be seen when all 34 active and all 5 repressive 
modifications are considered together (Figure D.1).  In this example, we also observe 
higher Pol II binding and RNA-seq expression levels in the predicted euchromatic 
domains than seen for the predicted heterochromatic domains (Figure 5.2), consistent 
with the expectation that euchromatin is more actively transcribed than heterochromatin.  
Furthermore, predicted euchromatic domains genome-wide have significantly higher 
average CD4
+
 T cell expression levels than the predicted heterochromatic domains 
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(Figure 5.3; Mann-Whitney U test P<1E-10).  The observations on expression levels 
serve to validate the maximum segment algorithm we use to delineate active 
(euchromatic) and repressive (heterochromatic) domains based on the analysis of histone 





Figure 5.2: Example of predicted chromatin domains.  An ideogram of chromosome 2 
shows the cytogenetic banding pattern along with the location of this specific example.  
The distributions of ChIP-seq tag mapping peaks for the active histone modification 
H3K79me1 (red bars), the repressive histone modification H3K27me2 (blue bars), Pol II 
binding (black bars) and RNA-seq tags (purple bars) are shown in separate tracks.  The 
predicted euchromatic domains (red bands) and heterochromatic domains (blue bands) 
are shown in the tracks denoted as „Euchromatin‟ and „Heterochromatin‟.  The locations 







Figure 5.3: Validation and analysis of predicted chromatin domains.  A: Average 
human CD4+ T cell expression levels for genes located in predicted euchromatic domains 
(grey bar) and heterochromatic domains (black bar).  B: Average RNA-seq tags per site 
in CD4+ T cell for predicted euchromatic domains (grey bar) and heterochromatic 




We also used Gene Ontology (GO) and KEGG pathway analyses to interrogate 
the functional relevance of the euchromatic and heterochromatic domains predicted with 
our algorithm.  Genes found in predicted euchromatic domains are enriched with 
functional terms and pathways related to CD4
+
 T cell functions, such as defense response 
(GO), systemic lupus erythematosus (KEGG) and antigen processing and presentation 





Boundary element prediction 
Application of the two-stage maximal segment algorithm and HMM approach 
(Figure 5.1) to the CD4
+
 T cell ChIP-seq data resulted in the identification of 2,542 
putative chromatin boundary elements.  Sequence features of these boundary elements 
are summarized in Table D.1.  It should be noted that our prediction method is not 
mechanistically biased in the sense that it does not rely on any previously known features 
of boundary element sequences, e.g. CTCF protein binding (122,131), the presence of 
tRNA genes (53) or the expression of non-coding RNAs originating from SINE repeats 
(56,79).  By predicting boundaries in this way, without regard to previously known 
features, we can evaluate the associations of putative boundaries with such features a 
posteriori and, more importantly, look for novel boundary element related features, 
which may be indicative of as yet unknown boundary element mechanisms.   
Examples of three predicted chromatin boundaries are shown in Figure 5.4; the 
locations of the boundaries are compared to the locations of the chromatin domains 
defined by active and repressive histone modification distributions along with the 
locations of CTCF binding, Pol II binding and RNA-seq expression levels.  All of these 
boundaries are located close to the edges of borders between adjacent chromatin domains 
and at sharp transition points of Pol II binding and RNA-seq levels.  The two boundaries 
shown in Figure 5.4.A are co-located with CTCF binding sites.  The boundary shown in 
Figure 5.4.B shows a similar chromatin profile to those in Figure 5.4.A but is not related 
to CTCF binding.  More detailed illustrations of these boundaries showing all of the 







Figure 5.4: Examples of predicted chromatin boundary elements.  A: Examples of 
predicted boundary elements with CTCF binding.  B: Example of a predicted boundary 
element without CTCF binding.  The predicted boundary elements are shown as green 
bands.  ChIP-seq peaks for active and repressive histone modifications, CTCF binding, 
Pol II binding and RNA-seq tags along with the locations of euchromatic domains, 







In order to test the relevance of the predicted chromatin boundaries to facultative 
chromatin and cell-type specific gene regulation, we compared the expression level 
differences for pairs of genes located on immediately opposing sides of the boundaries 
for CD4
+
 T cells to their expression level differences among a set of 78 different human 
tissues and cell types (99).  If the predicted boundary elements do in fact represent CD4
+
 
T cell specific regulatory elements that help to establish facultative chromatin domains, 
then the expression level differences of gene pairs that flank the boundaries should be 
greater for CD4
+
 T cells than for other tissue-types.  Consistent with this expectation, 
gene pairs that flank the predicted boundaries have significantly greater expression level 
differences in CD4
+
 T cells than in other tissues and cell-types (Figure 5.5; Mann-





Figure 5.5: Expression differences between gene pairs that flank boundary elements. 
Expression differences of gene pairs located on immediately opposing sides of predicted 
boundary elements are shown for CD4+ T cells (grey bar) and 78 other human tissues 






In an attempt to further evaluate the potential functional significance of the 
boundaries predicted here, we searched for overlaps between the predictions and 
previously experimentally characterized boundaries.  Among the few known boundaries 
that have been functionally verified, only one boundary element, the BEAD-1 element, 
was identified in human T cells.  BEAD-1 is a ~2kb region located between the 
divergently transcribed V 3 and TEA gene segments within the T cell receptor α/  locus, 
and it has been shown to have enhancer-blocking activity (132).  BEAD-1 is located 
within a RIT defined by our algorithm and overlaps one of the predicted boundary 
elements (Figure 5.6 and Figure D.4).  Previously, the BEAD-1 sequence was shown to 
have a CTCF binding site and its enhancer blocking activity was found to be CTCF 
dependent in an erythroleukemia cell line (51).  However, there is no evidence for CTCF 
binding of BEAD-1 from the genome-wide ChIP-seq analysis of CD4
+
 T cells (3) 








Figure 5.6: Co-location of a predicted boundary element with BEAD-1. A boundary 
element predicted by our method (green band) is shown to overlap with the 
experimentally characterized BEAD-1 boundary element (purple band).  The BEAD-1 
element is located between the V 3 and TEA gene segments (black boxes) of the T cell 
receptor α/  locus.  ChIP-seq peaks for active and repressive histone modifications, 
CTCF binding, Pol II binding and RNA-seq tags along with the locations of euchromatic 
domains, heterochromatic domains are illustrated as separate tracks (as in Figure 5.4).  




Chromatin features of predicted boundaries 
The boundary element predictions reported here are based solely on chromatin 
states inferred from histone modifications and Pol II binding and do not rely on any 
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previously characterized features of boundary element sequences.  Since boundary 
elements are known to have diverse mechanisms of action (43,44,48,133), we analyzed 
our predicted boundaries for enrichment with a number of previously characterized 
boundary features and also with respect to as yet unknown features that may suggest 
novel mechanisms of boundary element activity. 
We evaluated the chromatin environment of predicted boundaries using 
enrichment analysis of a number of genome-scale chromatin data sets.  To do this, the 
2,542 predicted boundary element regions were co-oriented and center aligned in such a 
way as to observe 8kb boundary element regions flanked by 8kb heterochromatic and 
euchromatic regions respectively.  Predicted boundary elements show marked enrichment 
for DNase I hypersensitivity consistent with an open chromatin environment (Figure 
5.7.A).  Twelve histone acetylation marks all show similar peaked patterns of enrichment 
over predicted boundaries compared to flanking heterochromatic and euchromatic 
regions, suggesting that the predicted boundary elements are specifically acetylated to 
facilitate opening of the chromatin and recruitment of sequence-specific DNA binding 







Figure 5.7: Chromatin signatures of predicted boundary elements.  A-F: 8kb 
boundary regions are shown together with 8kb flanking heterochromatic and euchromatic 
regions.  Normalized levels of DNase I hypersensitivity (A), fold enrichment profiles of 
12 histone acetylations (B), normalized levels of CTCF binding (C), normalized levels of 
YY1 binding (D), fold enrichment profiles of H3K27 mono-, di- and tri-methylations (E) 
and fold enrichment profiles of H3K9 mono-, di- and tri-methylations (F) are compared 




Levels of binding for the CTCF insulator protein are also elevated in predicted 
boundary element regions compared to adjacent heterochromatic and euchromatic 
regions (Figure 5.7.C).  Thus, the apparent acetylation activity at predicted boundary 
elements may be recruited by specific protein factors such as CTCF.  The importance of 
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CTCF in establishing chromatin regulatory domains recently was underscored by results 
indicating that numerous functional CTCF binding sites are constitutively occupied 
among different cell types, and more remarkably, conserved among syntenic regions in 
the human, mouse and chicken genomes (94).  However, it should be noted that only a 
minority of predicted boundary elements (777 or 30.6%) contain CTCF binding sites, 
suggesting that at some of the predicted boundaries acetylation events occur in a CTCF 














EVI1 382 0.022 Interacts with histone deacetylase, histone 
methyltransferases and CBP and P/CAF 
CEBP 249 2.27E-17 Interacts with CBP and p300 and promotes 
histone acetylation 
YY1 157 1.44E-17 Directs histone deacetylases and histone 
acetyltransferases to promoter 
CREBP1 150 5.87E-24 Essential in H2B and H4 acetylation, can 
interact with CBP HAT domain 
USF 140 2.50E-28 Recruits histone modifications at vertebrate 
boundary elements 
1 
The number of boundary elements containing the corresponding protein factor binding 
sites. 
2 
The statistical significance of the enrichment of the protein factor in predicted boundary 
elements assessed by hypergeometric test. 
3 




We used the conserved TFBS data from the UCSC Genome Browser (70,125) to 
search for protein binding sites that are significantly enriched among the set of predicted 
chromatin boundaries.  There are a number of significantly enriched TFBS that interact 
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with proteins directly or indirectly involved in chromatin remodeling events (Table 5.1).  
For example, EVI1, CEBP, CREBP1, USF and YY1 are all involved in chromatin re-
modeling via their interactions with chromatin modifying enzymes such as HAT, HDAC 
and HMT (134-140).  In addition, the transcription factor USF has previously been 
implicated as mediating chromatin boundary element activity (47,141).  The presence of 
distinct TFBS often overlap at individual boundaries indicating that a number of 
predicted boundaries have common binding sites (Figure D.5). 
Inferences on protein binding based on the presence of TFBS are prone to false 
positives (although the use of conserved sites greatly mitigates this possibility) and also 
do not yield information on cell-type specific binding.  For these reasons, we searched for 
ChIP-seq data sets from CD4
+
 T cells to validate the TFBS observed to be enriched at our 
predicted boundaries with experimentally characterized cell-type specific binding events.  
There are CD4
+
 T cell ChIP-seq data for YY1 (142), and analysis of these data reveal that 
the predicted boundaries are significantly overrepresented for YY1 binding (n=918; 
P≤10
-16
 hypergeometric test), and YY1 binding peaks at boundaries relative to adjacent 
chromatin (Figure 5.7.D).  Interestingly, there are far more boundaries bound by YY1 
(n=918) than boundaries with conserved YY1 TFBS (n=157).  This may be due to the 
presence of lineage-specific or non-canonical YY1 binding site motifs among the 
predicted boundaries.  Consistent with observations that YY1 is a cofactor of CTCF for 
X-chromosome inactivation (143), there is a highly significant overlap between 
boundaries bound by CTCF and YY1 (n=534; P≤10
-113
 hypergeometric test) suggesting 
the possibility of synergistic action between these two factors.  Nevertheless, there 
remain 384 boundaries with YY1 binding only suggesting CTCF-independent 
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mechanisms of action.  For example, evidence showing that YY1 can interact with both 
HDAC and HAT (144-150) led to a potential model proposing that YY1 can activate or 
repress transcription via changing the local chromatin environment (148).  YY1 was also 
shown to be able to interact with components of nuclear matrix (151,152), which may 
also facilitate partitioning of active and repressive chromatin domains.   
The specific methylation status, mono- di- or tri-methylation, of the H3K27 and 
H3K9 histone marks show divergent trends across predicted boundary elements 
containing regions and adjacent heterochromatic and euchromatic regions (Figure 5.7.E 
and Figure 5.7.F).  H3K27 and H3K9 mono-methylation (H3K27me1 and H3K9me1) 
levels increase steadily from facultative heterochromatic domains across boundary 
element containing regions and into euchromatic domains.  On the other hand, di- and tri-
methylation of the same residues (H3K27me2, H3K27me3, H3K9me2 and H3K9me3) 
gradually decrease from heterochromatin through the boundary element regions to 
euchromatin.  
A number of other histone methylation marks, along with non-protein-coding 
RNA-seq accumulation, also show steadily increasing levels across boundary element 
regions from facultative heterochromatin to euchromatin (Figure 5.8.A and Figure 5.8.B), 
consistent with a gradual opening of the chromatin.  However, all of the modifications of 
histone H3K4 analyzed here (H3K4me1, H3K4me2, H3K4me3 and H3K4ac) show 
distinct peaks over the predicted boundaries relative to flanking heterochromatic and 
euchromatic regions (Figure 5.8.C).  These particular histone modifications have been 
associated with promoter and/or enhancer activity, suggesting that boundary element 
mechanisms may be related to initiation of transcription (43), in the case of promoters, 
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and/or perturbation of the local chromatin environment, as has been suggested for 
enhancers (44).  The enrichment profiles of all histone modifications could be found in 





Figure 5.8: Chromatin and transcriptional transitions across predicted boundary 
elements. A-C: 8kb boundary regions are shown together with 8kb flanking 
heterochromatic and euchromatic regions. Fold enrichment profiles of 8 histone 
methylations (A), log2 transformed normalized non-protein-coding RNA-seq tags (B) 
and fold enrichment profiles of H3K4 histone modifications (C) are compared for 







Transcriptional interference at predicted boundaries 
Transcription of non-coding RNA has been shown to be important for boundary 
element function from yeast to higher eukaryotes (52,53,56,79).  Therefore, we analyzed 
RNA-seq data from CD4
+
 T cells in order to evaluate whether our predicted boundaries 
are transcriptionally active (95).  Across the predicted boundary elements, RNA-seq 
levels increase steadily with the transition from heterochromatin (low levels) to 
euchromatin (high levels) (Figure 5.8.B).  Interestingly, a subset of 77 predicted 
boundary elements contain annotated non-coding RNA genes (126,127) and show 
distinct peaks of RNA accumulation relative to the adjacent chromatin domains (Figure 
5.9.A), which coincide with Pol III binding (Figure 5.9.B).  The RNA-seq peaks indicate 
that these particular boundary locations are transcribed at markedly higher levels than 







Figure 5.9: Features of boundary elements containing RNA genes. A-B: 8kb 
boundary regions are shown together with 8kb flanking heterochromatic and euchromatic 
regions. Log2 transformed normalized RNA-seq tags (A) and normalized Pol III binding 
levels (B) of boundary elements containing RNA genes are compared for flanking 
regions and boundary regions. C: Example of boundary element containing tRNA genes. 
The predicted boundary element is shown as the green band.  ChIP-seq peaks for active 
and repressive histone modifications, CTCF binding, Pol II binding and RNA-seq tags 
along with the locations of euchromatic domains, heterochromatic domains and RefSeq 
genes are illustrated as separate tracks (as in Figure 5.2). Pol III binding (yellow bars) 






Figure 5.9.C shows an example of a predicted boundary element that contains a 
cluster of 4 tRNA genes along with peaks of RNA-seq expression and Pol III and CTCF 
binding, suggesting a possible relationship between CTCF binding and tRNA gene 
transcription.  The example shown in Figure 5.9.C suggests that, similar to yeast, tRNA 
genes in the human genome may operate as genomic boundaries, although definitive 
assessment of their functional significance awaits further experimental analysis.  
Consistent with this prediction, clusters of mouse tRNA genes have been shown to 
encode chromatin barrier activity (153). 
Discussion 
A chromatin based approach to unbiased boundary element prediction 
Boundary elements are known to organize chromatin into functionally distinct 
domains and to prevent regulatory cross-talk between domains.  Distinct boundary 
elements may act through a variety of mechanisms, and accordingly boundaries have 
been characterized phenotypically based on their activity rather than the presence of 
characteristic features.  Thus, boundary element prediction algorithms that use pattern 
detection methods to search for known boundary element characteristic features will 
result in biased sets of predictions that only reflect one or another of the known 
mechanisms of action.  This fundamental challenge to the computational prediction of 
boundary elements motivated our development and application of an unbiased algorithm 
that predicts the locations of putative boundary elements genome-wide based on their 
functional consequences, with respect to both chromatin and transcription states, as 
opposed to any intrinsic characteristics that they may possess. 
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Our approach to boundary element prediction relies on the delineation of adjacent 
active (euchromatic) and repressive (heterochromatic) domains based on the genomic 
distributions of active versus repressive histone modifications.  Regions in transition 
(RITs) between adjacent chromatin domains are further interrogated for the presence and 
location of putative boundaries using distributions of Pol II binding sites that serve as 
marks of active cell-type specific transcription.  Application of this two-stage chromatin 
boundary element prediction algorithm (Figure 5.1) to CD4
+
 T cell data resulted in the 
prediction of 2,542 boundary elements across the human genome.  The role of these 
predicted boundary elements in cell-type specific chromosomal domain organization was 
confirmed by the finding that genes immediately flanking boundaries are more highly 
differentially expressed in CD4
+
 T cells than seen for other human cells/tissues (Figure 
5.5).  Having predicted boundary elements in this way, we then analyzed the putative 
boundaries for the presence of a variety of features that may yield specific clues as to 
their potential mechanisms of action. 
Models for human boundary element activity 
Previous studies on boundary elements have suggested competing models that 
explain the mechanisms underlying boundary element activity.  The fixed model for 
boundary element activity implicates specific DNA sequences and their associated 
proteins, whereas the transcriptional interference model emphasizes the role of 
transcription from non-protein-coding transcriptional units.  We have previously noted 
that these two models are not necessarily mutually exclusive (43).  Under the fixed 
model, boundaries are precisely located and contain specific sequences that form discrete 
physical barriers between domains.  Specific sequence features are also needed to recruit 
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Pol II and Pol III machineries for the transcriptional interference model, and 
transcriptional units that act as boundaries may also form physical barriers that block the 
propagation of repressive chromatin.  The features uncovered for our predicted boundary 
elements can similarly be taken to suggest that the mechanisms of human boundary 
activity include aspects of both the fixed and transcriptional interference models. 
Analysis of the predicted boundary elements and surrounding RITs revealed two 
main features: 1) position-specific acetylation and open chromatin coincident with the 
recruitment of transcription factors such as EVI1, YY1 and USF (Figure 5.7.A, 5.7.B & 
5.7.D; Table 5.1), and 2) a gradual transition across RITs, from heterochromatin to 
euchromatin, of increasing histone lysine methylation and non-protein-coding RNA 
levels (Figure 5.7.E & 5.7.F; Figure 5.8.A & 5.8.B).  Considered together, these two 
observations lead us to propose a possible model for human boundary element activity 
(Figure 5.10).  Under this model, the specific positions of boundaries are established via 
the local recruitment of histone acetyltransferase (HAT) activity and transcription factors 
leading to the expression of non-protein-coding RNAs (Figure 5.10.A).  Boundary 
element function is maintained more broadly across RITs by the superposition of distinct 
and opposing chromatin modifying activities leading to the observed gradual transitions 
between heterochromatic and euchromatic histone lysine methylation and mediated by 







Figure 5.10: Model for human chromatin boundary element activity.  Broader 
regions in transition (RITs) from heterochromatin to euchromatin are shown along with 
more precisely located boundary elements.  A: Boundary element locations are 
characterized by position-specific open chromatin environment (DNase I 
Hypersensitivity Site) and hyperacetylation (Ac) that are coincident with the recruitment 
of transcription factors (TF) and non-protein-coding RNA transcription.  B: RITs are 
characterized by gradual changes in the levels of histone methylation (me) from 




Predicted boundary elements reside in regions of distinctly open chromatin and 
also show position-specific accumulations of 12 different histone acetylation marks 
(Figure 5.7.A and 5.7.B).  Previous studies have suggested boundary element activity is 
dependent upon the local recruitment of histone acetyltransferase activities to counteract 
the spread of repressive chromatin (141,154,155).  The patterns of histone lysine 
acetylation enrichment observed at position-specific location within predicted boundaries 
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are in agreement with already reported prominent role for histone acetylation at boundary 
elements and further corroborate the boundary prediction method used here.   
Along with the position-specific chromatin features and recruitment seen at 
predicted boundaries, we also observe distinct chromatin dynamics spread across the 
RITs that lie between adjacent facultative heterochromatic and euchromatic domains.  
For instance, H3K27 and H3K9 mono-methylation levels increase steadily from 
heterochromatic domains across boundary element containing regions and into 
euchromatic domains, whereas H3K27 and H3K9 di- and tri-methylation levels gradually 
decrease across the same intervals (Figure 5.7.E and 5.7.F).  This pattern can be taken to 
indicate a unidirectional activity of histone demethylation across RITs from 
heterochromatin to euchromatin.  At the same time, a number of other mono- di- and tri-
methylation histone marks show steady accumulations across RITs from heterochromatin 
to euchromatin (Figure 5.8.A) and are indicative of increased transcriptional activity 
(Figure 5.8.B) and/or the action of chromatin modifying enzymatic complexes associated 
with transcriptional elongation.   
H3K79 mono- di- and tri-methylation all show progressively increasing levels 
across RITs from facultative heterochromatin to euchromatin (Figure 5.8.A). While the 
exact function of H3K79 methylation is currently unknown, accumulation of these marks, 
catalyzed by the lysine methyltransferase (KMT) DOT1 (156), is correlated with actively 
transcribed protein-coding genes (157).  Accordingly, it is possible that H3K79 
methylation also marks active transcription of non-protein-coding RNAs across RITs as 
observed here (Figure 5.8.A & 5.8.B).  In fact, H3K79 methylation has previously been 
implicated in the stable maintenance of distinct chromatin states in yeast and mammalian 
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cells (158), and our data also suggests a possible, and previously unexplored, role for 
DOT1 in the establishment and maintenance of chromatin boundaries. 
Transcriptional regulators at predicted boundary elements 
The observations that predicted boundary elements contain binding site motifs for 
a number of proteins implicated in both the regulation of transcription and chromatin 
remodeling (Table 5.1), along with experimentally characterized YY1 binding (Figure 
5.7.D), are consistent with a role for transcriptional interference in human boundary 
element activity.  Involvement of transcription factors capable of maintaining a local 
active chromatin environment at boundaries has previously been reported by the 
Felsenfeld group in the context of the USF1 factor (47).  USF transcription factors can 
regulate Pol II transcription via direct interaction with components of the basic 
transcription machinery, such as TFIID and TBP associated factors (159), or through the 
recruitment of co-factors such as the histone acetyltransferase PCAF or the H3K4 histone 
methyltransferase SET7/92 (141).  Here, we observe a significant enrichment of the USF 
binding site motif (E-box element) among predicted boundaries.  Thus, we speculate that 
USF participates in the establishment and/or maintenance of human boundary element 
activity by triggering transcriptional interference, which may be mediated, at least in part, 
by the action of the aforementioned co-factors.   
EVI1 is another sequence-specific transcription regulator with binding sites that 
are over-represented among the boundary elements predicted here (Table 5.1).  EVI1 has 
been shown to interact with the histone acetyltransferase PCAF, the histone deacetylase 
HDAC1 and the histone methyltransferases SUV39H1 and G9A (134,135).  Thus, we 
speculate that EVI1 may function in boundary element activity by serving as a switch 
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between distinct chromatin remodeling activities thereby mediating the transition from 
heterochromatin to euchromatin in a cell-type dependent manner.  
Conclusions and prospects 
Chromatin boundary elements are major players in genome organization and 
regulation, but at this time there are relatively few examples of known boundary 
elements.  Here, we report a large collection of putative boundary elements for CD4
+
 T 
cells that span the entire human genome.  The boundaries reported here are computational 
predictions and thus must be treated with all due caution; nevertheless, analysis of the 
features of these boundaries yields results that are consistent with their roles as chromatin 
related regulatory elements.  We hope that the boundaries predicted here can serve as a 
prioritized list of targets for further experimental validation.  If validated experimentally, 
the predictions reported here could help to substantially enlarge the catalog of known 
chromatin boundary elements.  Our feature analysis of the predicted boundaries also 
raises the possibility of a mechanism of chromatin boundary activity in the human 
genome related to transcriptional interference.  This possibility awaits further detailed 
investigations. 
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CHROMATIN SIGNATURE DISCOVERY VIA HISTONE 





We report on the development of an unsupervised algorithm for the genome-wide 
discovery and analysis of chromatin signatures.  Our Chromatin-profile Alignment 
followed by Tree-clustering algorithm (ChAT) employs dynamic programming of 
combinatorial histone modification profiles to identify locally similar chromatin sub-
regions and provides complementary utility with respect to existing methods.  We applied 
ChAT to genomic maps of 39 histone modifications in human CD4
+
 T cells to identify 
both known and novel chromatin signatures.  ChAT was able to detect chromatin 
signatures previously associated with transcription start sites and enhancers as well as 
novel signatures associated with a variety of regulatory elements.  Promoter associated 
signatures discovered with ChAT indicate that complex chromatin signatures, made up of 
numerous co-located histone modifications, facilitate cell-type specific gene expression.  
The discovery of novel L1 retrotransposon associated bivalent chromatin signatures 
suggests that these elements influence the mono-allelic expression of human genes by 
shaping the chromatin environment of imprinted genomic regions.  Analysis of long gene 
associated chromatin signatures point to a role for the H4K20me1 and H3K79me3 
histone modifications in transcriptional pause release.  The novel chromatin signatures 
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and functional associations uncovered by ChAT underscore the ability of the algorithm to 
yield novel insight on chromatin based regulatory mechanisms.      
Introduction 
Histone proteins are subject to a variety of covalent modifications, including 
methylation, acetylation, phosphorylation and ubiquitylation.  The identities and locations 
of these histone modifications have profound effects on the structure and regulatory 
properties of eukaryotic chromatin (21).  Indeed, over the last several years specific 
genomic regulatory elements, such as promoters, enhancers and boundary elements have 
been associated with distinct combinatorial patterns of histone modifications (3,5,8-
11,18,23,28,33,95).  The discovery and characterization of such combinatorial histone 
modification patterns, or chromatin signatures as they are often referred to, can provide 
valuable information with respect to the location and activity of cell-type and 
developmentally-specific genomic regulatory features (7,13,14,17,22,25,31,34,160).  
Next-generation sequencing based technologies, chromatin immunoprecipitation 
followed by high throughput sequencing (ChIP-seq) in particular, provide an opportunity 
for the systematic analysis of combinatorial histone modification patterns genome-wide 
(19,161).  Computationally, the inference of combinatorial histone modification 
signatures is a pattern recognition problem in high-dimensional space. There are currently 
two classes of computational approaches designed for this purpose: supervised and 
unsupervised methods.  Supervised methods identify histone modification signatures 
characteristic of a pre-defined set of known genomic features, e.g. promoters or 
enhancers (9,27,28,34).  Regulatory element characteristic combinatorial modification 
patterns identified in this way can then be used to query the genome to identify the 
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locations of additional regulatory elements of the same kind.  The use of supervised 
methods in this way was critically important for the discovery that specific genomic 
regulatory elements bear distinct chromatin signatures.  However, supervised methods are 
unsuited for the discovery of novel histone modification patterns that may be associated 
with as yet unknown regulatory activities.  Unsupervised methods do not rely on training 
data sets derived from previously annotated features, and as such they have the potential 
to discover the kinds of unknown chromatin signatures that characterize novel regulatory 
elements.  Here, we are more interested in the unsupervised approach to the analysis of 
chromatin given the potential this approach holds for novel discoveries.   
There are a number of available unsupervised algorithms for the analysis of 
histone modification patterns.  The program ChromaSig utilizes probabilistic profiles that 
are characteristic of specific histone modification patterns (29,30).  The CoSBI algorithm 
applies a biclustering method to search for regions with common histone modification 
patterns (32).  Hidden Markov Model (HMM) based methods are widely used to segment 
eukaryotic genomes into various combinatorial chromatin states with distinct histone 
modification profiles (6,7,62).  The most recently developed method of this kind, 
Segway, employs Dynamic Bayesian Networks (DBN) to achieve greater precision for 
the detection of known regulatory elements along with superior accommodation of 
missing data (162). 
We have developed an unsupervised algorithm for analysis of combinatorial 
histone modification patterns that extends the capabilities of existing methods in a 
number of ways.  First, our method does not apply any restriction to the size of co-located 
histone modification patterns.  Second, our method does not utilize any motif seed to 
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initialize the subsequent inference of histone modification patterns.  Third, our method is 
capable of detecting histone modification patterns with multiple modes, e.g. co-located 
signatures made up of constituent individual modifications that are spatially shifted with 
respect to one another.  Fourth, our method is capable of detecting co-located signatures 
composed of alternating segments with conserved and variant combinatorial patterns.  
Fifth, our method discriminates between chromatin signatures composed of the same 
histone modifications but with different shapes.  Sixth, our method provides an inherent 
statistical criterion that allows related chromatin signatures to be classified into distinct 
groups, and thereby delineates the total number of patterns observed in any data set.  The 
first four features described above distinguish our method from the ChromaSig and 
CoSBI programs.  The fifth feature provides added utility beyond what is available for 
the HMM and Segway methods, and the sixth statistical feature is uniquely implemented 
in our approach.  
We call our method ChAT, for Chromatin-profile Alignment followed by Tree-
clustering, and we applied this approach to the genome-wide analysis of 39 histone 
modifications characterized by ChIP-seq analysis of human CD4
+ 
T cells (3,18).  
Application of ChAT on this data set resulted in the discovery of chromatin signatures 
previously shown to be characteristic of specific genomic regulatory elements along with 
a number of novel chromatin signatures and features that point to as yet unexplored 
chromatin related regulatory mechanisms.  We report these discoveries in light of the 
design and implementation of the ChAT algorithm, with an emphasis on comparison to 
existing methods.  The ability of the ChAT algorithm to discern combinatorial histone 
modification patterns previously observed to be associated with known regulatory 
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elements serves as proof of its utility for the discovery of functionally relevant chromatin 
signatures.  The characterization of previously undiscovered chromatin signatures and 
functional associations with ChAT supports the potential utility of the algorithm to yield 
novel biological insight. 
Materials and methods 
General scheme of the ChAT algorithm 
The ChAT algorithm analyzes genome-wide histone modification data sets 
produced via ChIP-seq in order to characterize distinct chromatin signatures.  ChAT is an 
unsupervised algorithm; its use does not require any training set based on pre-defined 
genomic annotations such as the locations of promoters, enhancers or transcription factor 
binding sites.  There are three major steps in the ChAT algorithm: 1) ChIP-seq data 
transformation, 2) dynamic programming on histone modification profiles, and 3) 
hierarchical clustering of genomic regions that correspond to related chromatin signatures 







Figure 6.1: Scheme of the ChAT algorithm. (A) For a series of  genomic regions, 
combinatorial histone modification distributions are represented by ChIP-seq profile 
matrices.   (B) Histone modification ChIP-seq tag counts are smoothed and transformed 
to produce normalized scores.  (C) Dynamic programming is used to identify sub-regions 
with similar chromatin signatures. (D) Pairwise p-values are computed based on a null 
distribution of high-scoring chromatin segment pairs (islands) found between unrelated 
genomic regions.  (E) Pairwise p-values are organized into a distance matrix that is used 






ChIP-seq data transformation 
The genome is divided into 200bp non-overlapping bins, and for each bin arrays 
of ChIP-seq signals (i.e. tag counts) for all histone modifications in the data set are 
computed.  In this way, combinatorial histone modification profiles are represented as a 
matrix, where the column vectors correspond to combinatorial histone modification tag 
counts within individual genomic bins and the row vectors correspond to the contiguous 
genomic landscape of individual histone modifications (Figure 6.1.A).  Then for each 
individual histone modification (i.e. each row vector), Gaussian smoothing is applied to 
remove noise resulting from spurious tag counts in the ChIP-seq experiments (Figure 
6.1.B).  The resulting smoothed ChIP-seq tag counts for each histone modification are 
transformed to a score between 0 and 1 for all subsequent analysis (Figure 6.1.B).  




esc 11 , where sc is the transformed score and 
t is the smoothed tag count.  iT  is the genomic median of tag counts of histone 
modification i .  The transformation is performed for two reasons.  First, the vast majority 
of bin tag counts for each histone modification are very small (e.g. 1 or 2 tags), and the 
transformation allows such regions to be effectively excluded from subsequent analysis.  
Second, large differences between high bin tag count values (e.g. 100 versus 150 tags) 
can bias subsequent alignment steps, and the transformation allows the magnitude of such 
differences to be dampened.  
Having quantified and transformed ChIP-seq histone modification tag count 
signals in this way, the algorithm then divides the genome into discrete genomic regions 
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(Figure 6.1.A) by delineating contiguous regions that contain high ChIP-seq signals for at 
least one histone modification from intervening regions that do not contain any such 
signal.  The intervening genomic regions that do not contain any high ChIP-seq signal are 
excluded from subsequent analysis, and the contiguous genomic regions with high ChIP-
seq signal are taken as discrete units for subsequent alignment and chromatin signature 
analysis.  To do this, consecutive genomic bins with high ChIP-seq signals ( 5.0sc ) are 
first merged into a single region, and regions which are close to each other (<4kb) are 
further merged together.  Importantly, at this step no size threshold or limit for 
contiguous regions is used.  This allows the algorithm to characterize chromatin 
signatures across a wide range of genomic sizes.  In addition, consecutive bins do not 
need to be enriched with the same histone modification in order to be merged.  This 
allows the algorithm to characterize chromatin signatures with spatially shifted patterns 
of individual histone modifications. 
To make the algorithm more computationally efficient, individual genomic 
regions with similar histone modification profiles are grouped together prior to profile 
alignment with dynamic programming.  This grouping is achieved via a simple two-step 
clustering procedure.  First, genomic regions are checked for presence or absence of a set 
of user-defined histone modifications (e.g. H3K4me3, H3K27ac, H3K27me3 and 
H3K36me3), and regions are grouped together if they contain the same sets of these 
modifications.  This step reflects the fact that regions which differ with respect to the 
presence/absence of critical user-defined histone modifications are unlikely to have 
similar chromatin signatures.  Second, genomic regions are further grouped into three 
size categories: small (≤5kb), medium (>5kb and <10kb) and large (≥10kb).  This initial 
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grouping greatly reduces the number of pairwise profile alignments needed to be 
performed.  It also allows for intelligent user input with respect to the coherence of 
functionally related (e.g. active versus repressive) histone modifications.  
Dynamic programming on histone modification profiles 
For every pair of genomic regions within the same group, local pairwise 
alignment of transformed histone modification profile matrices is performed using 
dynamic programming.  The dynamic programming approach entails a number of 
advantages: it does not require any prior chromatin signature motif seed, it guarantees 
optimal local alignments that can include gaps, it allows for the discovery of chromatin 
signatures of vastly different sizes, and it allows for the calculation of p-values that 
quantitatively measure chromatin signature similarities between genomic regions. 
To perform dynamic programming, the transformed histone modification profile 
matrix of each discrete genomic region is considered as a string of column vectors and a 
modified cosine similarity is used as the score to measure the similarity between each 
pair of column vectors (Figure 6.1.C).  For example, the column vector for bin i of the 
first region (region 1) of a pair under comparison is denoted as 1iv .  Each entry of this 
column vector corresponds to the transformed score for the level of a specific histone 
modification, e.g. 1ikv is the value for the kthhistone modification in bin i . Similarly, the 
vector for bin j of the second region (region 2) of a pair under comparison is denoted as 
2
jv  and 
2
jkv is the value for the kth  histone modification in bin j .  The raw score for the 
similarity between 1iv and 
2
















jv .  The value of ijs
~ is more likely to be negative with higher values of f  and 
accordingly the two bins will have lower probability of being aligned.  Thus, increasing 
the value of f will cause the alignment to be more stringent.  Here, f is set to 2 for small 
sized region comparisons in order to focus on highly similar sub-regions and is set to 1.5 
for medium and large size comparisons. 
The raw score is further multiplied by a weight factor to calculate the final score 
for 1iv  and 
2
jv .  The final score is ijsws
~  and the weight factor is related to 




ew .  Thus vectors with 
small norms are given small weight; the rationale being that vectors with small norms 
have low levels of ChIP-seq signals and therefore should contribute less to the final 
signatures even if they are very similar with each other.  is used to control the 
stringency of the weight factor.  Larger values of  result in smaller weights, and 
accordingly only genomic regions with abundant ChIP-seq signals will be aligned.  Here, 
is set as 0.3. 
The gap penalty is designed to be proportional to the vector norm.  For example, 
the gap penalty of aligning 1iv to a gap is 
11
ii vkg .  The gap penalty scheme is designed 
such that it highly penalizes the alignment of vectors with large norms (i.e. high levels of 
ChIP-seq signals) to gaps.  The parameter k is used to control the stringency of the 
alignment, and it is designed to be larger for small size region comparisons and smaller 
for medium and large size comparisons.  The introduction of gaps using this scheme 
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enables the discovery of multi-modal chromatin signatures, particularly for large-sized 
signatures that often contain combinations of conserved and variant segments.  
Having parameterized the dynamic programming algorithm in this way, it is then 
used to search for the most similar sub-regions between pairs of transformed histone 
modification matrices representing discrete genomic regions.  Each entry of the 
alignment matrix for dynamic programming is: 
}0,,,max{ 1 11,
2
1,1,1,1 ijijjiijjiji gcgcscc , and 0,0 ,00, ji cc .  Each pair of 
regions is compared twice: in the same and in the opposite orientations.  In this way, sub-
regions with the highest combinatorial histone modification profile similarities will be 
found. 
P-values are calculated to quantify the similarities between genomic sub-regions 
aligned in this way (Figure 6.1.D).  To do this, the algorithm employs the island method, 
based on the extreme value distribution of high-scoring segment pairs, originally 
developed for DNA sequence comparisons (72).  This method creates a null distribution 
of random similarity scores, against which the observed similarity scores can be 
compared in order to compute p-values for aligned pairs of sub-regions.  To create the 
null distribution of random similarity scores, pairs of unrelated genomic regions are 
randomly sampled from the entire set of regions under consideration.  Then for each pair 
of unrelated regions, dynamic programming with the same parameter settings is applied 
and all high-scoring islands of similarity, with scores above a threshold t , are retained.  
Using those high-scoring islands, the parameters tK  and t  for the extreme value 
distribution are estimated as suggested by Altschul et al (163), and finally the p-value is 
calculated as:
xt
tmneKep 1 . 
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Hierarchical clustering of related chromatin signatures 
All p-values for pairwise profile alignments are organized into a pairwise distance 
matrix, and hierarchical clustering is applied on this matrix (Figure 6.1.E).  In this way, 
sub-regions with the same combinatorial histone modification signatures will be grouped 
together and the branch lengths among them in the hierarchical tree will be shorter.  
Furthermore, since p-values are used as pairwise distances, the branch lengths can be 
viewed as approximate p-values among sub-groups or clusters.  Then, for a given p-value 
threshold (e.g. 0.05), the hierarchical tree divided by this threshold will yield clusters of 
related sub-regions at user-defined levels of statistical confidence (Figure 6.1.E).  
Cluster-characteristic combinatorial histone modification signatures can then be derived. 
Chromatin signature feature enrichment analysis 
Chromatin signatures discovered via the application of ChAT to genome-wide 
histone modification data sets are evaluated for the enrichment over annotated genomic 
features (e.g. promoters and enhancers) using a fold enrichment (FE) criterion: 
qpFE / , where p is the fraction of the patterns overlapping with specific genomic 
features, and q  is the fraction of the specific genomic feature in the genome.  Here, an 
FE threshold of 3 was taken to indicate that a given chromatin signature is enriched over 
a particular genomic feature.  The features analyzed include TSS (8kb sequences centered 
on the transcription start sites of Refseq gene models), TTS (8kb sequences centered on 
the transcription termination sites of Refseq gene models), enhancers (CD4
+
 T cell 
specific p300 binding sites) (164) and CD4
+





The ChAT algorithm for chromatin signature discovery 
As its name implies, the ChAT algorithm analyzes genome-wide maps of histone 
modifications characterized by ChIP-seq studies via a process of Chromatin-profile 
Alignment followed by Tree-clustering.  To do this, chromatin profiles are represented as 
numeric matrices with transformed scores for each histone modification along the 
genomic sequence (Figure 6.1.A and 6.1.B).  Alignment of these profiles is performed 
using an implementation of the local dynamic programming algorithm, which allows for 
the detection of genomic sub-regions with shared chromatin profiles (Figure 6.1.C).  
Dynamic programming also allows for the introduction of gaps in the chromatin profile 
alignments.  Gaps are critical since they allow the algorithm to extend beyond regions 
with variant (or diffuse) chromatin enrichment signatures, and in so doing facilitate the 
discovery of chromatin signatures that span long genomic regions as well as those with 
complex multi-modal patterns of histone modification enrichment.  For each resulting 
pairwise chromatin profile alignment, an approximate p-value is calculated (Figure 
6.1.D), and hierarchical clustering is then applied on these pairwise values to organize 
genomic regions into related groups of chromatin signatures (Figure 6.1.E).  The use of 
p-values for clustering allows for an inherent statistical criterion by which the 
hierarchical tree can be divided into groups of coherent chromatin signatures.  
Application of ChAT to CD4+ T cell chromatin 
We applied the ChAT algorithm to the analysis of genome-wide maps of 39 
histone modifications characterized using ChIP-seq on human CD4
+
 T cells (3,18) in an 
attempt to discover all discernible histone modification patterns.  ChAT was run using the 
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parameter values described in the Materials and Methods section, and a p-value threshold 
of 0.05 was used to partition the resulting hierarchical trees of patterns in order to 
explicitly delineate individual chromatin signatures.  As stated previously, application of 
ChAT to ChIP-seq histone modification data sets does not require any restriction on the 
size of potential chromatin signatures or the use of motif seeds to initialize the search.  
ChAT identified a total of 206 distinct combinatorial histone modification 
patterns genome-wide, which were subsequently grouped into small- (144), medium- (35) 
and large-sized (27) categories as explained in the Materials and Methods.  Overall, the 
features of these observed chromatin signatures are consistent with the intended design of 
the algorithm and point to the additional utility provided by its use.  For instance, we 
detected a number of large-sized patterns, ranging from 10kb – 100kb, which 
demonstrate the utility of allowing alternating conserved and variant segments in the 
detection scheme.  We also find a number of signatures with multiple modes of histone 
modifications as well as spatially shifted patterns for individual constituent 
modifications.  Combinatorial patterns that bear the same individual histone 
modifications with different relative profile shapes are recognized as distinct chromatin 
signatures.  
Inspection of the small-sized patterns revealed that a substantial fraction of these 
signatures are associated with known regulatory features, such as TSS, TTS and p300 
binding sites (Table E.1).  41.7% of the small-sized patterns are enriched with DNase I 
hypersensitive sites, using a fold enrichment threshold of 3 (FE>3), implying that they 
are located in open chromatin and possibly co-located with individual regulatory 
elements.  In the following sections, we describe a number of the chromatin signatures 
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discovered by ChAT, with an emphasis on the characterization of known regulatory 
features, which serve as a kind of positive control for the approach, along with 
descriptions of previously uncharacterized patterns that underscore the ability of the 
algorithm to facilitate novel discoveries. 
TSS associated chromatin signatures 
Since chromatin signatures around active TSS have been previously well-
characterized (3,9), we searched for ChAT identified chromatin signatures that are co-
located with annotated TSS in an attempt to evaluate the performance of the algorithm.  
There are 36 small-sized signatures that were found to be enriched at TSS (Table E.1; 
FE>3), and the common characteristic histone modifications of these patterns include the 
canonical TSS associated marks H3K4me3, H2AZ, H3K4me1 and H3K9me1 as well as a 
number of other combinations of histone acetylations, which are known active marks.  








Figure 6.2: Transcription start site (TSS) associated chromatin signatures.  (A) A 
TSS associated signature based on enrichment of H3K4me3. (B) A TSS associated 
signature composed of 5 active histone modifications. (C) A bivalent TSS associated 






Figure 6.2.A shows the histone modification enrichment profile of the simplest 
TSS signature, which is characterized by H3K4me3 alone.  In Figure 6.2.B, the TSS 
associated signature is shown to be enriched with 5 co-located active histone 
modifications.  Interestingly, a number of bivalent TSS associated signatures were also 
found by ChAT.  For example, the bivalent signature shown in Figure 6.2.C is 
characterized by 3 co-located active marks and a spatially shifted and multi-modal 
enrichment of the repressive mark H3K27me3.  From the perspective of the ChAT 
algorithm design, the enrichment profiles of the bivalent signature example (Figure 
6.2.C) illustrate the ability of the program to find patterns with multiple modes caused by 
shifted enrichments of different histone modifications.   
Analysis of expression levels (99) in CD4
+
 T cells for sets of genes  with TSS 
marked by distinct signatures show that bivalent signatures are associated with lower 
gene expressions than seen for active signatures (p=4.1x10
-4
, Mann-Whitney test) (Figure 
6.3.A).  Furthermore, the lower gene expression levels associated with bivalent 
signatures, and higher gene expression levels associated with active signatures, are 
specific to T cells and B cells compared with expression levels in other cell types (Figure 
6.3.B).  This observation indicates cell-type specific regulatory functions of distinct TSS 
associated combinatorial histone modification signatures discovered by ChAT for CD4
+
 







Figure 6.3: Differential gene expression associated with specific TSS chromatin 
signatures.  (A) Median CD4+ T cell expression levels (+/- 1 quartile) of genes with TSS 
marked by 36 distinct chromatin signatures.  Bivalent TSS signatures (blue bars) 
correspond to lower overall expression levels than active signatures (orange bars).  (B) 
Cell-type specific gene expression patterns associated with different TSS chromatin 
signatures.  Gene expression levels across 79 cell types (red=high and green=low) are 
shown for genes with TSS marked by a bivalent signature versus genes with TSS marked 
by an active signature.  Expression differences are most pronounced for the indicated T 




We also observed that sets of genes with similar T or B cell expression levels can 
show very different TSS associated chromatin signatures.  For instance, Figure 6.4.A 
shows two sets of genes with indistinguishable T or B cell expression levels (p=0.7, 
Mann-Whitney test), but different levels of expression (p=4.9x10
-3
, Mann-Whitney test) 
across a panel of numerous other cell-types and tissues (99).  In other words, the first set 
(s1) has a narrower cell-type specific expression pattern, whereas the second set (s2) 
shows broad expression over numerous cell-types and tissues (Figure 6.4.A).  The 
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chromatin signature for the set of cell-type specific genes (s1, Figure 6.4.B) is far more 
complex, being comprised of six different histone modifications, than the signature made 
up of two histone modifications seen for the set of broadly expressed genes (s2, Figure 
6.4.C).  This suggests the possibility that cell-type specific expression is regulated via a 
more complex chromatin promoter landscape.  In fact, when all 36 of the TSS related 
chromatin signatures are evaluated, more complex signatures are found to be associated 
with gene sets that have higher T or B cell-type specific expression levels (Figure 6.4.D).  
The acetylation marks H3K36ac and H3K27ac in particular are associated with high 














Figure 6.4: Cell-type specific expression associated with complex chromatin 
signatures.  (A) Average (±sd) expression levels (blue-T or B cell expression, grey-other 
cell-type expressions) of genes with TSS marked by two different chromatin signatures 
(s1 and s2).  (B) Enrichment profiles showing the average histone modification scores 
across signature s1.  (C) Enrichment profiles showing the average histone modification 
scores across signature s2.  (D) Box-plots showing T or B cell specific expression level 




TTS associated chromatin signatures 
The nature of chromatin signatures around TTS have not been previously 
characterized as well as those associated with TSS (6,15,162), and this may be due to a 
lack of coherence in the histone modification patterns found at gene termini.  
Nevertheless, ChAT was able to discern 9 small-sized patterns associated with TTS in 
CD4
+
 T cells (Table E.1; FE>3).  The common characteristic marks for these TTS 
signatures are quite distinct from those seen around TSS and include H2BK5me1, 
H4K20me1 and H3K27me1.  Two examples of TTS associated signatures are shown in 
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Figure 6.5.A and 6.5.B.  A single genomic region showing adjacent locations of each of 
these two signatures close to an annotated TTS is shown in Figure 6.5.C.  Both of these 
TTS patterns are bi-modal with two enriched peaks linked by a relatively depleted central 
region.  The relatively low levels of histone modifications seen in the central regions of 
these patterns may be related to specific protein binding events as has been suggested for 
the bi-modal patterns of enhancers (7).  Consistent with this possibility, these same sets 
of regions show peaks of RNA polymerase II (Pol II) binding that corresponds to the 
locations of the depleted regions in the bi-modal patterns (Figure 6.5.D and 6.5.E).  With 
respect to the ChAT algorithm design, the bi-modal patterns seen at TTS point to the 
utility of gaps in the chromatin profile alignments, which allow chromatin patterns to 











Figure 6.5: Transcription termination site (TTS) associated chromatin signatures.  
TTS signatures associated with three (A) and two (B) histone modification combinations 
are shown (histone modification representations described as for Figure 6.2).  (C) A 
specific TTS proximal locus showing adjacent locations of each of these two patterns.  
(D) Pol II enrichment profile within genomic regions marked by the signature shown in 
panel A.  (E) Pol II enrichment profile within genomic regions marked by the signature 




Enhancer associated chromatin signatures 
Chromatin signatures characteristic of enhancers have been characterized in a 
number of studies (7,9,11,27-30), many of which rely on the positions of p300 binding 
sites to identify enhancer locations.  We also took the locations of p300 binding sites 
(164) to indicate putative enhancers and found that ChAT characterized 18 small-sized 
signatures that are co-located with these sites (Table E.1; FE>3).  The common 
characteristic marks of these patterns include the canonical enhancer associated marks 
H3K4me1 and H3K4me3 along several other histone acetylations (Figure 6.6.A).  
Examples of enhancer associated signatures detected by ChAT are shown in Figure 6.6.B 
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and 6C; these two distinct signatures are characterized by similar sets of histone 
modifications with markedly different profile shapes, i.e. mono-modal (Figure 6.6.B) 
versus bi-modal (Figure 6.6.C).  The different shapes of this kind discovered by ChAT 
may point to distinct dynamics of histone modifying enzymes and/or DNA binding 
proteins between the two sets of enhancers, indicative of the utility of the algorithm for 





Figure 6.6: Enhancer associated chromatin signatures.  A ~100kb genomic region 
with three locations marked by a specific signature composed of co-located peaks. (B) 
Histone modification enrichment profiles of an enhancer associated mono-modal 






Conserved non-coding element associated chromatin signatures 
Conserved non-coding elements (CNEs) are non protein-coding sequences that 
have been found to be anomalously conserved between species; CNEs are of interest 
because they are thought to correspond to regulatory regions that have been conserved by 
purifying selection based on their functional utility (165).  We evaluated CNEs 
characterized via the comparison of genome sequences from 28 vertebrate species for the 
presence of chromatin signatures discovered with the ChAT algorithm and found that all 
144 signatures show substantial overlap (FE>3) with the CNEs (Figure 6.7.A and Table 
E.1).  This result is consistent with the presumed regulatory activity of CNEs.  Not 
surprisingly, most of the CNE associated signatures are made up of active histone marks 
and tend to be associated with TSS or enhancers; such CNEs are likely to be active 
regulatory elements in CD4
+
 T cells.  However, a number of CNEs were also found to be 
associated with repressive chromatin signatures.  For example, a simple chromatin 
signature made up of the repressive mark H3K27me3 (Figure 6.7.B) is highly enriched 
over CNEs (FE=18.4).  We surmised that these CNEs may represent regulatory elements 
that are active in other cell-types but repressed in a specific manner in T or B cells.  To 
evaluate this possibility, we checked the expression levels of the genes most proximal to 
these CNEs for their expression across 79 human tissues and cell-types (99).  These 
genes do appear to be repressed in T or B cells in a cell-type specific manner, since they 
are expressed at higher levels across other cell types compared to T or B cells (Figure 







Figure 6.7: Conserved non-coding element (CNE) associated chromatin signatures.  
(A) Distribution of fold enrichments of CNEs for all small-sized signatures.  (B) Histone 
modification enrichment profiles (as described for Figure 6.2) for a repressive signature 
highly enriched within CNEs.  (C) Cell-type specific expression levels for genes 
proximal to CNEs bearing the repressive signature shown in panel B.  (D) Distribution of 
the ratios of T or B cell average expressions and other cell type average expressions for 
genes shown in panel C (observed=red expected=grey).  Observed ratios are significantly 
smaller than expected ratios calculated from gene expression levels randomly simulated 







Bivalent chromatin signatures associated with L1 retrotransposons 
Bivalent chromatin signatures, composed of co-located active and repressive 
histone modifications (12,16), have previously been associated with TSS sequences, and 
the ChAT algorithm was also able to detect such bivalent signatures at TSS in CD4
+
 T 
cells (Figure 6.2.C and 6.3).  Application of ChAT here revealed two bivalent signatures 
that were not found to be associated with TSS: H3K9me3 and H3K36me3 (Figure E.1) 
along with H3K4me3 and H3K9me3 (Figure 6.8.A).  Interestingly, both of these bivalent 
signatures were found to be highly enriched within L1 retrotransposon sequences; 68.4% 
of the genomic regions marked by the H3K9me3-H3K36me3 signature overlap with L1 
as do 77.0% of genomic regions marked by H3K4me3 and H3K9me3.  A broad genomic 
region with several L1 encoded segments that overlap the H3K4me3-H3K9me3 





Figure 6.8: A bivalent chromatin signature associated with L1 retrotransposons.  
(A) Histone modification enrichment profiles (as described for Figure 6.2) for the 
bivalent signature.  (B) A single genomic region with three locations marked by the L1 






This particular bivalent pattern has previously been associated with imprinted 
genomic loci wherein genes tend to be expressed in a mono-allelic fashion based on the 
parent of origin for the allele (16).  Interestingly, a number of studies have also shown 
that L1 retrotransposons are enriched in-and-around imprinted genomic loci (166-169).  
Thus, the enrichment of these bivalent signatures on L1 retrotransposons may point to a 
chromatin based mechanism by which L1 sequences contribute to the mono-allelic 
expression of human genes.  On the other hand, such bivalent patterns may actually result 
from ChIP-seq analyses performed heterogeneous cell populations with the locations in 
some cells marked by active modifications and others with repressive modifications.  In 
this case, the patterns revealed by the algorithm would represent an artifact of the ChIP-
seq experimental design. 
Large-sized chromatin signatures 
The ChAT algorithm places no restriction on the size of chromatin signatures that 
it can identify, and we found 27 large-sized signatures in CD4+ T cells ranging from 
10kb – 100kb in length.  These large-sized chromatin signatures can be classified into 
two groups.  The first group contains long contiguous co-located blocks of repressive 
marks, presumably representing heterochromatic or repressive chromatin domains.  The 
second group shows more complex and potentially interesting patterns resembling the 
known H3K4me3-H3K36me3 domains, which are associated with gene bodies and long 
non-coding RNAs (3,8,170).  For example, the signatures shown in Figure 6.9.A and 
6.9.B (see also Figures E.2 and E.3) are characterized by the presence of similar active 
marks albeit over different size ranges.  In both cases, the long chromatin signatures show 
punctate enrichments of several active marks at one end of the pattern together with 
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broader enrichments of different active marks throughout the rest of the signature.  These 
two large-sized signatures show substantial overlaps with gene bodies (Figure 6.9.C), 
suggesting the utility of ChAT for annotating genes.  
However, while more than 90% of these two large-sized signatures do overlap 
with known gene bodies (Figure 6.9.D), there is still a small fraction which does not 
overlap with gene bodies.  For example, Figure 6.9.E shows two specific genomic 
regions where the signatures do not overlap with annotated gene models.  Inspection of 
RNA-seq and spliced EST data from these regions suggests the possibility that the 
regions marked by these chromatin signatures represent as yet uncharacterized alternative 
promoters of nearby genes.  
The biggest difference in the enrichment levels for any individual mark between 
these two patterns is seen for H3K36me3, a mark of transcriptional elongation (3,7).  
Consistent with this observation, genes marked by these two chromatin signatures show 
different expression levels in CD4
+
 T cells (p=0.016; Figure 6.9.F).  These data 
underscore the functional relevance of slight differences in chromatin signatures that are 








Figure 6.9: Large-sized chromatin signatures associated with gene bodies.  (A & B) 
Histone modification enrichment profiles are shown for two chromatin signatures 
composed of the same constituent modifications and spatial patterns with distinct sizes.  
(C) Specific instances of each signature co-located with human gene bodies.  (D) 
Percentage of these two large-sized signatures that overlapping with gene bodies 
(grey=any coverage, blue>50% coverage, orange>80% coverage, red >95% coverage of 
the gene body).  (E) Two examples where signature B is co-located with individual 
genomic regions that are annotated as intergenic but show evidence of being genic.  (F) 






Both of these long chromatin signatures show enrichment of H4K20me1 and 
H3K79me3 that tend to be located within gene bodies and start just downstream of TSS 
(Figure 6.9.A-C).  This suggests the possibility that these marks are associated with 
transcriptional pause release, a phenomenon whereby Pol II complexes paused at 
promoter regions are allowed to proceed into gene bodies to facilitate active transcription 
of the genes (171,172).  Previously, the relative levels of bound Pol II seen in promoter 
proximal versus downstream regions have been used to evaluate the extent of 
transcriptional pause release (173,174).  Here, we show that the ratio of gene body-to-
TSS Pol II density is positively correlated with the gene body levels of H4K20me1 
(Figure 6.10.A) and H3K79me3 (Figure 6.10.B) consistent with a role for these marks in 
transcriptional pause release.     
The discoveries of those complex large-sized signatures highlight the 
performance of ChAT with respect to several aspects of the algorithm design.  First of all, 
the large-size of these signatures underscores the advantage of predicting chromatin 
signatures without size restrictions.  Second, the prediction of large-sized signatures was 
facilitated by the ability of the algorithm to extend histone modification profile 
alignments through the use of gaps in the dynamic programming implementation.  Third, 
the complex histone modification enrichment profiles apparent in these signatures, i.e. the 
specific enrichments of several histone modifications over a narrow range of the pattern 
and the broad enrichments of other marks in the rest of the pattern, demonstrates the 
ability of the algorithm to detect patterns with spatially shifted multi-modal enrichments 







Figure 6.10: Transcriptional pause release associated with H4K20me1 and 
H3K79me3.  The ratio of Pol II density downstream of TSS (+1kb~+5kb) over its 
density around TSS (-1kb~+1kb) is positively correlated with the density of downstream 





We developed ChAT (Chromatin-profile Alignment followed by Tree-clustering) 
an unsupervised algorithm for the discovery and characterization of recurrent 
combinatorial histone modification patterns, i.e. chromatin signatures.  ChAT utilizes a 
novel dynamic programming and hierarchical clustering approach to relate and group 
similar chromatin signatures dispersed across the genome.  The algorithm was explicitly 
designed to provide complementary utility with respect to existing methods.  For 
example, ChAT can identify chromatin signatures across a vast range of different sizes, it 
finds multi-modal chromatin signatures composed of individual histone modifications 
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that are spatially shifted as well as complex signatures composed of conserved and 
variant segments, and ChAT can also distinguish between chromatin signatures that are 
made up of the same constituent histone modifications with different shapes.  The 
algorithm also employs an explicit statistical criterion that provides confidence levels for 
the grouping of similar chromatin signatures.   
We applied ChAT to the analysis of genome-wide histone modification maps in 
human CD4
+
 T cells.  The algorithm was able to discern combinatorial histone 
modification patterns previously observed to be associated with genomic regulatory 
features such as TSS and enhancers, serving as a proof of its utility for the discovery of 
functionally relevant chromatin signatures.  Perhaps more interestingly, we were also 
able to discover a number of previously unknown chromatin signatures with ChAT.  For 
example, we discovered novel chromatin signatures associated with TTS, enhancers and 
CNEs.  We were also able to uncover functional associations, based on enrichment of 
chromatin signatures at specific genomic regulatory features, which point to novel 
chromatin based mechanisms of gene regulation.  For example, we found evidence for 
the role of complex chromatin signatures, made up of numerous co-located histone 
modifications, in the cell-type specific regulation of human genes.  We also found 
evidence suggesting that L1 retrotransposons can influence the mono-allelic expression 
of human genes by creating a local genomic environment enriched for specific bivalent 
chromatin signatures.  Finally, novel long chromatin signatures found to be associated 
with human genes suggest a role for the H4K20me1 and H3K79me3 histone 
modifications in transcriptional pause release.  The discovery of these novel chromatin 
signatures and functional associations underscores the potential utility of the algorithm to 
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provide novel biological insight and to help focus future experimental efforts for the 
characterization of chromatin based regulatory mechanisms.  
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In summary, this dissertation is composed of five computational algorithms 
developed for ChIP-seq datasets of epigenomics research. The first two algorithms 
belong to the basic data processing field, and they serve essentially to reduce noise and 
retrieve real genomic locations of histone modifications and/or transcription factors. In 
CHAPTER 2, a read mapping algorithm is developed to deal with ambiguous ChIP-seq 
tags, and in CHAPTER 3 a peak calling method is designed to identify broad peaks for 
diffuse ChIP-seq signals. The next three algorithms are question-driven methods that 
apply pattern recognition techniques for basic biological discoveries. While CHAPTER 4 
focuses on a hypothesis-driven pipeline for insulator predictions, CHAPTER 5 introduces 
an unbiased hypothesis-free approach for predicting chromatin boundary elements. In 
CHAPTER 6, an unsupervised algorithm is developed to explore novel combinatorial 
chromatin signatures that are associated with various genomic features. 
While next-generation sequencing technologies have produced large amounts of 
sequence tags that make many large-scale biological analyses applicable now, the very 
short sequences cause new computational problems when they are mapped back to the 
reference genomes. One problem is related to the ambiguity of multi-mapping tags. 
CHAPTER 2 presents a Gibbs sampling strategy to solve this problem. Theoretical 
derivations are discussed, and it guarantees the optimality of the performance from the 
Bayesian statistics point of view. Applying the method on simulated datasets, it has 
substantial improvements on the fractions of correctly mapped ambiguous reads 
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compared with previous methods. Furthermore, the accuracy of recovering the real sites 
is also improved by using this algorithm. More detailed analysis of the recovered sites in 
different repetitive genomic regions supports the utility of this algorithm for finding more 
signals within those previously under-investigated regions. 
As another critical step for basic data processing, several peak calling methods 
have been developed. Most of those methods restricted on calling sharp peaks that are 
characteristic for transcription factors and some histone modifications. There are certain 
histone modifications well known for their diffuse distributions and methods for 
identifying broad peaks are lacking. CHAPTER 3 presents a maximal scoring segment 
algorithm based method for broad peak calling. A parameter estimation module is 
constructed using Gibbs sampling procedures on non-homogeneous Poisson processes. 
The global observations of the shifted enrichments of H3K36me3 and H3K79me2 broad 
peaks along gene bodies, along with the enrichments of CTCF bindings around the edges 
of the resulted H3K27me3 broad peaks, indicate that the performance of this algorithm 
fits well with a priori biological knowledge. Evaluations on simulated datasets further 
prove the superior performance compared with existing methods for large broad peak 
calling. 
One of the important epigenomics question relates to the identity and locations of 
insulator elements in the human genome. Inspired by experimental observations 
summarized from a subset of insulators, a hypothesis-driven pipeline is designed in 
CHAPTER 4 to predict locations of a subset of insulators: MIR-insulators. This pipeline 
integrates both genomics and epigenomics features and finally generated a set of 1,178 
MIR-insulators in CD4
+
 T cells in the human genome. Several selected MIR-insulators 
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are experimentally tested using EBAs in both human kidney cell lines and zebrafish 
embryos. Specific local chromatin signatures are found for the putative MIR-insulators. 
Their distance distributions to TSS imply the evolutionary dynamics of insulators. 
Functional annotations of genes proximal to those MIR-insulators show an interesting 
enrichment of TCR pathway. This observation, along with specific examples, raises the 
importance of MIR-insulators on cell type specific regulations. A global analysis of those 
MIR-insulators found a large fraction of them to be functional in a cell type specific 
manner. 
A related, but different, type of regulatory element is chromatin boundary 
elements. These boundary elements play an important role in epigenomics because they 
can organize large-scale chromatin domain configurations and presumably related with 
three-dimensional structures. In order to address the lack of unified features of the 
currently known barriers, CHAPTER 5 developed an unbiased hypothesis-free algorithm 
to search for boundary elements in an attempt to discovering novel features. In order to 
do that, chromatin boundaries are modeled as transition points between chromatin states 
and a HMM based method is designed. As an indication of the good performance, the 
canonical boundary element, BEAD1 element, is successfully found. The resulted 
boundaries can be classified into CTCF dependent and independent groups. To search for 
novel features, sequence analysis shows a set of transcription factor binding motifs 
enriched within the predicted boundaries. It includes EVI1, CREBP1, USF and YY1. All 
of these proteins have interesting interactions with chromatin modifying enzymes, and 
USF has even been shown to be related to one canonical boundary element 
experimentally before. The most interesting feature analysis comes from the finding of a 
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subset of boundaries containing non-coding RNA genes. It is the first report of potential 
non-coding RNA gene, specifically tRNA, derived boundaries in the human genome, 
although similar observations were found in yeast and mouse before.  This computational 
predication was later experimentally confirmed. 
 Given the large number of different histone modifications existing in the genome, 
the complex relationships between combinations of histone modifications and various 
genomic features have been an important topic in epigenomics research. CHAPTER 6 
built an unsupervised algorithm for the discovery of combinatorial chromatin signatures 
in the genome. This algorithm is based on a high-dimensional profile alignment strategy 
and bears a set of inherent advantages compared to previous methods, such as free of size 
restrictions, the capability of finding multi-mode patterns, the discrimination between 
patterns with different profile shapes and the statistical criteria for pattern identifications. 
Applications of this method on human CD4
+
 T cell epigenome datasets produced a set of 
interesting combinatorial chromatin signatures. These signatures are further analyzed by 
comparing with various genomic features. These associations support the performance of 
this method for discovering novel combinatorial chromatin signatures and the utility of 





















Libraries tag length signal to noise ratio sequencing error 
rate 
Library 1 35 99 2/5L 
Library 2 35 99 4/5L 
Library 3 35 9 2/5L 
Library 4 35 9 4/5L 
Library 5 20 99 2/5L 
Library 6 20 99 4/5L 
Library 7 20 9 2/5L 
Library 8 20 9 4/5L 
Big Library 20 9 4/5L 
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 Table A.2. Comparison of the number of sites identified using unique tags only 
versus using unique and ambiguous tags with the Gibbs sampling method. 
 
  Lib 1 Lib 2 Lib 3 Lib 4 Lib 5 Lib 6 Lib 7 Lib 8 Lib Big 
th Total site 51278 51278 51278 51278 51278 51278 51278 51278 173877 
4 Unique 42886 42454 42729 42302 38631 36760 38515 36729 144751 
Unique TP 42869 42446 42712 42290 38625 36759 38515 36729 144638 
Gibbs 46127 45857 45957 45762 43848 43225 43693 43036 162991 
Gibbs TP 45470 45264 45315 45124 43123 42551 43002 42347 162501 
Improvement 2601 2818 2603 2834 4498 5792 4498 5624 17863 
Fraction 5.07% 5.50% 5.08% 5.53% 8.77% 11.30% 8.77% 10.97% 10.27% 
6 Unique 41264 40600 41120 40454 36364 32253 36284 32100 126452 
Unique TP 41262 40599 41118 40452 36363 32252 36282 32099 126402 
Gibbs 45142 44500 44957 44369 42383 41347 42254 41229 158139 
Gibbs TP 44622 44060 44452 43902 41826 40879 41724 40734 157929 
improvement 3360 3461 3334 3450 5463 8627 5442 8635 31527 
fraction 6.55% 6.75% 6.50% 6.73% 10.65% 16.8% 10.61% 16.84% 18.13% 
8 Unique 39351 37967 39214 37856 32816 24852 32667 24918 98044 
Unique TP 39350 37966 39214 37855 32815 24851 32666 24918 98018 
Gibbs 43520 42023 43317 41879 40631 38340 40501 38287 149200 
Gibbs TP 43115 41705 42921 41555 40221 38031 40098 37950 149076 
improvement 3765 3739 3707 3700 7406 13180 7432 13032 51058 











Figure A.1. Recall and precision of 3 algorithms under various tag count thresholds 
(4 tags and 8 tags). A. Illustration of data used to test algorithm performances. B. 
Variant tag thresholds could cause differences in the performance test. The lines (red and 
green) are two tag thresholds. C. Barplots of recall and precision for the three methods 
(MAQ-dark blue, fraction method-light blue, Gibbs method-green) on 8 libraries under 















Table A.3. Algorithm performance on 8 sequence tag libraries. 
 















library 1 8409 2581 1435 3558 2387 3241 2601 
library 2 8832 2378 1395 3434 2452 3403 2818 
library 3 8566 2573 1444 3490 2352 3228 2603 
library 4 8988 2378 1418 3397 2432 3460 2834 
library 5 12653 3009 1997 4737 3588 5217 4498 
library 6 14519 3409 2643 5583 4669 6465 5792 
library 7 12774 3077 2049 4806 3628 5178 4498 






library 1 10016 1912 1366 3164 2582 3878 3360 
library 2 10679 1749 1325 2994 2580 3900 3461 
library 3 10160 1849 1371 3110 2579 3837 3334 
library 4 10826 1699 1303 2968 2555 3915 3450 
library 5 14915 2718 2287 4777 4230 6019 5463 
library 6 19026 4155 3883 7427 7060 9094 8627 
library 7 14996 2701 2282 4699 4140 5970 5442 






library 1 11928 1476 1258 2875 2632 4169 3765 
library 2 13312 1352 1186 2685 2533 4056 3739 
library 3 12064 1446 1252 2753 2521 4103 3707 
library 4 13423 1309 1176 2643 2491 4023 3700 
library 5 18463 3186 3032 6174 5930 7815 7406 
library 6 26427 5868 5798 11547 11425 13488 13180 
library 7 18612 3256 3089 6190 5944 7834 7432 








Table A.4. Algorithm performance for recall and precision together.   
 
thresholds 4 6 8 
criteria recall precision F recall precision F recall precision F 
Library_1 MAQ 0.17 0.56 0.26 0.14 0.71 0.23 0.11 0.85 0.19 
Fraction 0.28 0.67 0.39 0.26 0.82 0.39 0.22 0.92 0.36 
Gibbs 0.31 0.80 0.45 0.34 0.87 0.49 0.32 0.90 0.47 
Library_2 MAQ 0.16 0.59 0.25 0.12 0.76 0.21 0.09 0.88 0.16 
Fraction 0.28 0.71 0.40 0.24 0.86 0.38 0.19 0.94 0.32 
Gibbs 0.32 0.83 0.46 0.32 0.89 0.47 0.28 0.92 0.43 
Library_3 MAQ 0.17 0.56 0.26 0.13 0.74 0.22 0.10 0.87 0.18 
Fraction 0.27 0.67 0.38 0.25 0.83 0.38 0.21 0.92 0.34 
Gibbs 0.30 0.81 0.44 0.33 0.87 0.48 0.31 0.90 0.46 
Library_4 MAQ 0.16 0.60 0.25 0.12 0.77 0.21 0.09 0.90 0.16 
Fraction 0.27 0.72 0.39 0.24 0.86 0.38 0.19 0.94 0.32 
Gibbs 0.32 0.82 0.46 0.32 0.88 0.47 0.28 0.92 0.43 
Library_5 MAQ 0.16 0.66 0.26 0.15 0.84 0.25 0.16 0.95 0.27 
Fraction 0.28 0.76 0.41 0.28 0.89 0.43 0.32 0.96 0.48 
Gibbs 0.36 0.86 0.51 0.37 0.91 0.53 0.40 0.95 0.56 
Library_6 MAQ 0.18 0.78 0.29 0.20 0.93 0.33 0.22 0.99 0.36 
Fraction 0.32 0.84 0.46 0.37 0.95 0.53 0.43 0.99 0.60 
Gibbs 0.40 0.90 0.55 0.45 0.95 0.61 0.50 0.98 0.66 
Library_7 MAQ 0.16 0.67 0.26 0.15 0.84 0.25 0.17 0.95 0.29 
Fraction 0.28 0.75 0.41 0.28 0.88 0.42 0.32 0.96 0.48 
Gibbs 0.35 0.87 0.50 0.36 0.91 0.52 0.40 0.95 0.56 
Library_8 MAQ 0.18 0.77 0.29 0.21 0.93 0.34 0.21 0.99 0.35 
Fraction 0.31 0.83 0.45 0.37 0.95 0.53 0.43 0.99 0.60 
Gibbs 0.39 0.89 0.54 0.45 0.95 0.61 0.49 0.97 0.65 
Library_Big MAQ 0.28 0.92 0.43 0.30 0.99 0.46 0.29 1.00 0.45 
Fraction 0.46 0.95 0.62 0.53 0.99 0.69 0.56 1.00 0.72 

















Table A.5. Algorithm performance on the bigger sequence tag library. 
 










4 29239 8963 8272 14330 13594 18240 17863 
6 47475 14475 14314 25181 25034 31687 31527 











Table B.1: The summary of recall, precision and F score for BroadPeak, SICER and 



























BroadPeak 0.44 0.53 0.55 0.39 0.46 0.51 0.38 0.43 0.47 
SICER 0.07 0.07 0.07 0.04 0.04 0.04 0.03 0.03 0.03 
RSEG 0.60 0.38 0.19 0.31 0.21 0.12 0.24 0.18 0.11 
 
Precision 
BroadPeak 0.69 0.74 0.73 0.60 0.66 0.64 0.55 0.60 0.58 
SICER 0.78 0.84 0.89 0.66 0.74 0.82 0.52 0.63 0.74 
RSEG 0.29 0.65 0.89 0.24 0.55 0.82 0.18 0.44 0.71 
 
F score 
BroadPeak 0.54 0.62 0.63 0.47 0.54 0.57 0.45 0.50 0.52 
SICER 0.12 0.12 0.13 0.08 0.07 0.08 0.06 0.06 0.06 
















Figure B.1: Enrichment of CTCF binding around broad peak edges of H3K9me3 
identified by BroadPeak. The blue curve shows the enrichment profile of H3K9me3 
within and around the identified broad peaks and the pink curve shows the enrichment 



























Figure B.2: Examples of H3K36me3 broad peaks identified by supervised and 
unsupervised parameter estimations. Examples of the supervised peaks (red) and 
unsupervised peaks (purple) are compared with the gene bodies (blue) and the tag 









Figure B.3: Examples of broad peak calling by BroadPeak, SICER and RSEG on 
one simulated library. The identified broad peaks by RSEG (purple), SICER (orange) 



























Table C.1: Spearman correlations between upstream and downstream histone 








H2AK5ac -0.23 2.3E-8 
H2AK9ac -0.79 3.1E-81 
H2BK5ac -0.39 1.2E-41 
H2BK12ac -0.47 2.7E-55 
H2BK20ac -0.24 3.7E-16 
H2BK120ac -0.36 5.9E-36 
H3K4ac -0.41 1.4E-44 
H3K9ac -0.55 1.3E-82 
H3K14ac -0.85 1.6E-21 
H3K18ac -0.20 3.1E-12 
H3K23ac -0.76 3.6E-61 
H3K27ac -0.37 2.3E-37 
H3K36ac -0.43 4.9E-49 
H4K5ac -0.32 1.7E-27 
H4K8ac -0.28 9.6E-21 
H4K12ac -0.70 8.5E-84 
H4K16ac -0.44 5.7E-45 
H4K91ac -0.33 6.8E-29 
H2AZ -0.18 10.0E-10 
H2BK5me1 -0.36 3.7E-34 
H3K4me1 -0.06 1.5E-2 
H3K4me2 -0.38 4.1E-41 
H3K4me3 -0.32 1.0E-29 
H3K9me1 -0.41 5.0E-49 
H3K9me2 -0.78 1.6E-37 
H3K9me3 -0.63 6.5E-48 
H3K27me1 -0.42 3.4E-47 
H3K27me2 -0.72 7.2E-66 
H3K27me3 -0.47 1.0E-31 
H3K36me1 -0.70 1.0E-56 
H3K36me3 -0.43 3.7E-52 
H3K79me1 -0.54 3.2E-80 
H3K79me2 -0.72 3.5E-146 
H3K79me3 -0.69 3.4E-139 
H3R2me1 -0.33 6.6E-20 
H3R2me2 -0.72 1.2E-12 
H4K20me1 -0.45 1.3E-55 
H4K20me3 -0.64 1.2E-17 











Figure C.2:  Scheme and results of the principal components analysis around 
predicted MIR-insulators.  Above, the joined histone modification arrays are shown 
along the first three principal component arrays that result from the PCA analysis.  
Below, a three-dimensional plot showing the locations of individual active (red) and 


















Figure C.3:  Cumulative distributions of the CD4+ T cell gene expression levels for 





























Figure C.4:  Cumulative distributions of the differences in the gene expression levels 
for genes proximal to MIR-insulators.  Difference distributions are shown for CD4+ T 






























Table C.2: Genomic coordinates of three MIR-insulators and their corresponding 






















































































Figure C.5:  Distance distributions between MIR-insulators and the nearest gene 
















Figure C.6:  T cell receptor pathway illustration from KEGG database.  Genes 






















Figure C.7:  Cell type-specific chromatin barrier activity and gene regulation by 
MIR-insulators from the T cell receptor pathway.  ChIP-seq fold enrichment levels 
around MIR-insulators proximal to the 21 T cell receptor genes are shown for H3K4me3, 
H3K36me3 and H3K27me3 in CD4+ T cells (black), GM12878 cells (red) and K562 
(orange) cells.  Insets show the average differences (± standard error) between the active 
versus repressive domains surrounding MIR-insulators for the marks and cells.  
Significance of the differences between CD4+ T cells and other cells are indicated as * 
P<0.05 ** P<0.01 *** P<0.001.  Average gene expression levels (± standard error) are 
shown for genes located in the active domain side proximal to MIR-insulators at the 21 T 













Table D.1: Sequence features of RITs and predicted boundary elements. 
 
 RIT Boundary element 
Median size 68.6kb 8kb 
GC content 0.421 0.423 
CpG O/E 0.229 0.316 
Genic fractions 43.0% 40.9% 
 
1
The ratio of observed CpG frequency to expected CpG frequency. 
2
































Figure D.1: Example of predicted chromatin domains. An ideogram of chromosome 2 
shows the cytogenetic banding pattern along with the location of this specific example.  
The distributions of ChIP-seq tag mapping peaks for the active histone modification (red 
bars), the repressive histone modification (blue bars) are shown in separate tracks.  The 
predicted euchromatic domains (red bands) and heterochromatic domains (blue bands) 





Table D.2: Enriched gene ontology and KEGG terms of genes in predicted 
euchromatin domains with high gene densities. 
 





ATP dependent helicase activity 0.039 
Defense Response 0.045 
Glycerophospholipid Biosynthetic Process 0.056 
Regulation of Response to External Stimulus 0.069 




Systemic Lupus Erythematosus 0 

























Figure D.2: Examples of predicted boundary elements with CTCF binding. The 
predicted boundary elements are shown as green bands.  ChIP-seq peaks for active and 
repressive histone modifications, along with the locations of euchromatic domains and 







Figure D.3: Example of a predicted boundary element without CTCF binding. The 
predicted boundary element is shown as green bands.  ChIP-seq peaks for active and 
repressive histone modifications, along with the locations of euchromatic domains and 








Figure D.4: The predicted boundary element overlapping with BEAD-1. The 
predicted boundary element is shown as the green band.  ChIP-seq peaks for active and 
repressive histone modifications, along with the locations of euchromatic domains and 









Figure D.5: Overlaps between conserved TFBSs. A. Heatmap showing the degrees of 
pairwise overlaps between TFBSs; B. Matrix showing the numbers of pairwise overlaps 









Figure D.6: Enrichment profiles around boundary elements of histone modifications 
which show distinct peaks. The average fold enrichments (y-axis) of individual histone 
modifications are ploted for the predicted boundary elements (8kb), the heterochromatin 





Figure D.7: Enrichment profiles around boundary elements of histone modifications 
which increase from heterochromatin to euchromatin. The average fold enrichments 
(y-axis) of individual histone modifications are ploted for the predicted boundary 






















Figure D.8: Enrichment profiles around boundary elements of histone modifications 
which decrease from heterochromatin to euchromatin. The average fold enrichments 
(y-axis) of individual histone modifications are ploted for the predicted boundary 


















Table E.1: Enrichments of small-size combinatorial histone modification patterns 















 36 (25.0%) 21 (14.6%) 8 (5.6%) 
TTS
c
 9 (6.3%) 0 0 
p300
d
 18 (12.5%) 16 (11.1%) 12 (8.3%) 
DNase I
e
 60 (41.7%) 51 (35.4%) 40 (27.8%) 
CNE
f
 144 (100.0%) 142 (98.6%) 137 (95.1%) 
 
a
FE: ratios of the fractions of patterns overlapping with the specific features over the 
genomic fractions of the corresponding features. 
b
TSS: transcription start site. 
c
TTS: transcription termination site. 
d
p300: binding sites of p300. 
e
DNase I: DNase I hypersensitive sites. 
f
CNE: Conserved non-coding elements predicted based on sequence alignments of 28 























Figure E.1: Histone modification profiles for H3K36me3-H3K9me3 bivalent 
pattern. Genomic locations with this specific bivalent pattern are aligned and levels of 
H3K36me3 and H3K9me3 are shown as heatmaps on the left (yellow - higher levels, 
blue - lower levels). The average profiles of histone modifications of this pattern are 































Figure E.2: Average histone modification profiles for the large pattern example A. 
Each curve shows the average profile of a specific histone modification of genomic 


























Figure E.3: Average histone modification profiles for the large pattern example B. 
Each curve shows the average profile of a specific histone modification of genomic 
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